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Summary 
Plants rely on a multi-layered, cell autonomous immune system to combat a plethora of 
pathogens. While a first, broad defence response is sufficient to restrict growth of most 
invaders, some pathogens have evolved means to overcome this. In an evolutionary arms 
race plants have evolved intracellular receptors that recognise host-adapted pathogens and 
initiate a sustained and potent immune response call ETI (effector-triggered immunity). 
EDS1 (ENHANCED DISEASE SUSCEPTIBILITY 1) and its signalling partners PAD4 
(PHYTOALEXIN DEFICIENT 4) or SAG101 (SENESCENCE-ASSOCIATED GENE 101) 
form a central convergence point for those intracellular receptors and act as a decision-
making node for SA (salicylic acid) dependent and SA independent transcriptional 
reprogramming. Despite our increasing knowledge about plant immunity the molecular 
function of the EDS1/PAD4 complex and how these proteins are regulated remains unclear. 
Recent work established an antagonistic regulation between the JA (jasmonic acid) key TF 
(transcription factor) MYC2 and EDS1. While MYC2 enhances bacterial virulence by 
repressing the EDS1 promoter, ETI activated EDS1 represses MYC2 signalling and 
dampens pathogen growth. This cross-regulation represents an intersection of ETI and JA 
signalling and allows fine-tuning of the plant’s immune response. How EDS1 controls 
MYC2 accumulation and activity is not known. 
Here, I show regulation of MYC2 abundance and MYC2 transactivation activity by EDS1 
family proteins. Further, I present evidence for the underlying molecular mechanisms of this 
regulation and identify new components in this pathway. Specifically, PAD4 and SAG101 
but not EDS1, stabilise MYC2 protein while EDS1 but not PAD4 or SAG101, promote 
MYC2 transactivation activity. Thus, protein accumulation is not indicative of MYC2 
transcriptional output. MYC2 activity promotion is lost in a JAZ repressor uncoupled MYC2 
variant (MYC2s) or when co-expressed with the bacterial virulence protein avrRPS4, 
indicating i) regulation of JAZ proteins by EDS1 and ii) immunity context dependent 
regulation of MYC2. Functional characterisation of this regulation shows that besides JAZ 
repression MYC2 is phosphorylated in an EDS1 dependent manner. In eds1-2 plants 
MYC2S123 is phosphorylated, suggesting that EDS1 either represses a protein kinase or 
activates a protein phosphatase. I show interaction of the protein kinase EDR1 
(ENHANCED DISEASE RESISTANCE 1), a negative regulator of plant immunity, with 
PAD4 and with MYC2 in Arabidopsis (Arabidopsis thaliana) protoplasts. Whether EDS1 
regulates MYC2 via EDR1 or another, so far unknown, component remains to be tested.  
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Results presented in this work provide insights into the regulatory relationship of EDS1 and 
MYC2. EDS1 promotes MYC2 transactivation activity as shown by enhanced MYC2 target 
gene expression. Molecularly, EDS1 regulates MYC2 via JAZ proteins and likely via 
MYC2 phosphorylation. More detailed analysis will be necessary to address this entirely. 
Ultimately, the impact of the presented data depends on the functional relevance of this 
regulation. For this, in planta experiments in pathogen challenged and unchallenged 
conditions will be key.  
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Zusammenfassung 
Pflanzen sind auf ein vielschichtiges, zellautonomes Immunsystem angewiesen, um eine 
Vielzahl von Krankheitserregern zu bekämpfen. Während eine erste, breite Abwehrreaktion 
ausreicht, um das Wachstum der meisten Eindringlinge einzuschränken, haben einige 
Krankheitserreger Wege gefunden, um dies zu überwinden. In einem evolutionären 
Wettrüsten haben Pflanzen intrazelluläre Rezeptoren entwickelt, die wirtsangepasste 
Pathogene erkennen und eine dauerhafte und starke Immunantwort (ETI - Effektor-
ausgelöste Immunität) auslösen. EDS1 (ENHANCED DISEASE SUSCEPTIBILITY 1) und 
seine signalgebende Partnerproteine PAD4 (PHYTOALEXIN DEFICIENT 4) oder SAG101 
(SENESCENCE-ASSOCIATED GENE 101) bilden einen zentralen Konvergenzpunkt für 
diese intrazellulären Rezeptoren und fungieren als Entscheidungsknoten für SA 
(Salicylsäure) abhängige und SA-unabhängige Umprogrammierung der Genexpression. 
Trotz unseres zunehmenden Wissens über die Immunität von Pflanzen ist die molekulare 
Funktion des EDS1 / PAD4-Komplexes und dessen Regulierung unklar. Jüngste Arbeiten 
haben eine antagonistische Regulierung zwischen dem JA (Jasmonsäure)-Kern-TF 
(Transkriptionsfaktor) MYC2 und EDS1 etabliert. Während MYC2 die bakterielle Virulenz 
durch Unterdrückung des EDS1-Promotors verstärkt, unterdrückt ETI-aktiviertes EDS1 den 
MYC2-Signalweg und dämmt das Wachstum von Erregern ein. Diese Kreuzregulierung 
stellt eine Kreuzung von ETI- und JA-Signalwegen dar und ermöglicht eine 
Feinabstimmung der pflanzlichen Immunantwort. Wie EDS1 die Menge und Aktivität von 
MYC2 steuert, ist nicht bekannt. 
Hier zeige ich die Regulierung der MYC2 Menge und der MYC2 Transaktivierungsaktivität 
durch Proteine der EDS1-Familie. Darüber hinaus präsentiere ich die molekularen 
Mechanismen dieser Regulation und identifiziere neue Komponenten in diesem Signalweg. 
Insbesondere stabilisieren PAD4 und SAG101, aber nicht EDS1, das MYC2-Protein, 
während EDS1, nicht jedoch PAD4 oder SAG101 die MYC2 Transaktivierungsaktivität 
fördert. Daher ist die Proteinakkumulation kein Indikator für die Aktivität von MYC2 als 
TF. Die Erhöhung der MYC2 Aktivität geht in einer JAZ-entkoppelten MYC2-Variante 
(MYC2s) oder bei gleichzeitiger Expression des bakteriellen Virulenzproteins avrRPS4 
verloren, was auf i) die Regulierung von JAZ-Proteinen durch EDS1 und ii) die immun-
kontextabhängige Regulation von MYC2 hinweist. Die funktionale Charakterisierung dieser 
Regulierung zeigt, dass MYC2, neben Regulation durch JAZ-Proteine, EDS1-abhängig 
phosphoryliert wird. In eds1-2 Pflanzen ist MYC2S123 phosphoryliert, was darauf schließen 
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lässt, dass EDS1 entweder eine Proteinkinase unterdrückt oder eine Proteinphosphatase 
aktiviert. Ich zeige die Interaktion der Proteinkinase EDR1 (ENHANCED DISEASE 
RESISTANCE 1), einem negativen Regulator der Pflanzenimmunität, mit PAD4 und mit 
MYC2 in Arabidopsis (Arabidopsis thaliana) Protoplasten. Ob EDS1 MYC2 über EDR1 
oder eine andere bisher unbekannte Komponente reguliert, muss noch getestet werden. 
Die in dieser Arbeit präsentierten Ergebnisse geben Einblick in die regulatorischen 
Beziehungen zwischen EDS1 und MYC2. EDS1 fördert die MYC2 
Transaktivierungsaktivität, wie durch die verstärkte Expression von MYC2 abhängigen 
Genen gezeigt wird. Insgesamt reguliert EDS1 die MYC2 Aktivität über JAZ-Proteine und 
wahrscheinlich über MYC2 Phosphorylierung. Eine genauere Analyse wird jedoch 
erforderlich sein, um dieses Problem vollständig zu lösen. Letztendlich hängt die 
Wichtigkeit der dargestellten Daten von der funktionalen Relevanz dieser Regulierung ab. 
Um dies zu klären, werden in planta Experimente in Pathogen infizierten und nicht-
infizierten Bedingungen ausschlaggebend sein. 
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1 Introduction 
Given the evolutionary distance between plants and animals, their innate immune systems 
are rather alike. Both rely on a two-phase system that firstly recognises intruders via 
unspecific, commonly present clues. Secondly, a more specific and more powerful immune 
response is initiated. Compared to animals, plants face numerous complications in terms of 
pathogen and pest defence. Being sessile organisms, plants cannot physically move away 
from pathogen pressure. Further, plants cannot rely on mobile, highly specialised immunity 
cells, since the cell wall prevents cell motility. Rather, every individual cell needs to be 
equipped with the full defence potential. This is reflected by the fact that plants do not 
possess adaptive immunity like animals, but rather an innate and a systemic immune 
response. In the past 20 years we have gained extensive insights into the sophisticated 
principles of the plant immunity network (Dangl et al. 2001, Jones et al. 2006) and while we 
understand pathogen recognition and subsequent defence outputs rather well, our knowledge 
on signal integration and decision-making remains limited. 
1.1 Recognition of conserved microbial patterns - an initial barrier 
for pathogens 
The first layer of plant immunity is typically referred to as non-host, or basal immunity. It 
relies on perception of pathogens via cell surface receptors called PRRs (pattern recognition 
receptors) that recognise conserved molecular patterns common to most microbes. PRR 
mediated immunity is therefore called PAMP- (pathogen-associated molecular pattern) or 
MAMP- (microbe-associated molecular pattern) triggered immunity (PTI) (Zipfel 2009). 
This form of immune response is usually potent enough to restrict growth of host non-
adapted microbes. The Arabidopsis (Arabidopsis thaliana) genome encodes more than 600 
PRR genes of which almost half are up-regulated by biotic stresses (Lehti-Shiu et al. 2009). 
Of this plethora of PRRs, numerous members have been characterised and shown to differ in 
their phylogenetic distribution, epitope recognition, and interaction partners. The best 
characterised PRR is FLS2 (FLAGELLIN SENSING 2). Upon recognition of the bacterial 
peptide flg22 (flagellin), FLS2 and its signalling partner BAK1 (BRASSINOSTEROID 
INSENSITIVE1-ASSOCIATED KINASE 1) phosphorylate the cytoplasmic kinase BIK1 
(BOTRYTIS-INDUCED KINASE 1), which in turn phosphorylates the NADPH oxidase 
RBOHD (RESPIRATORY BURST OXIDASE HOMOLOGUE D). This results in an 
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antimicrobial ROS (reactive oxygen species) burst. In parallel, activated FLS2/BAK1 induce 
MAPK (MITOGEN-ACTIVATED PROTEIN KINASE) signalling leading to WRKY TF 
phosphorylation and ultimately to transcriptional reprogramming (Couto et al. 2016, Wang 
et al. 2018). A hallmark of PTI is its rapid induction with kinase phosphorylation and ROS 
burst occurring within 5-10 min after receptor activation. 
 
1.2 NLR resistance - the next level 
Selection pressure on pathogens to overcome PTI led to the evolution of effector proteins 
that suppress PTI and cause ETS (effector-triggered susceptibility). These virulence factors 
have numerous structures and functions and many are secreted into the plant cell, usually via 
a T3SS (type III secretion system) to suppress PTI. In an arms race plants evolved 
intracellular receptors that sense bacterial effector proteins and trigger a second, more 
powerful immune response named ETI (effector-triggered immunity). These intracellular 
receptors resemble mammalian NOD-like receptors and are called nucleotide binding 
domain-leucine rich repeat receptors (NLRs). Dependent on their N-terminal domain NLRs 
can be further specified into CC-NLRs (coiled-coil domain, CNLs) and TIR-NLRs (Toll-
Interleukin1-Receptor domain, TNLs) (Jones et al. 2016). The long-standing dogma of NLR 
signalling was that each NLR represents a R (resistance) gene that directly recognises a 
bacterial effector, thereby conferring resistance (fitting the gene-for-gene hypothesis) (Flor 
1971, Ellis et al. 2000, Jones et al. 2016). In this scenario pathogens face substantial 
selective pressure to evolve their effector proteins in order to dodge plant immunity. 
Likewise, plants have to keep up with effector diversification by adapting existing or 
inventing new R genes. Nowadays a more universal notion is accepted.  
Besides direct NLR-effector interaction, other recognition mechanisms have been proposed 
and characterised. Numerous NLRs do not directly detect an effector, but monitor effector 
target proteins, so called “guardees”, or “decoys”. Hence, modification of a guardee/decoy 
leads to NLR activation. While the function of guardees and decoys is similar, guardees 
usually have an additional role in immune signalling. Decoys, however, serve exclusively as 
baits for effectors. A variation of the decoy model is a class of NLRs with an integrated 
decoy domain. Here, the NLR contains an effector virulence target domain. Combination of 
these recognition mechanisms enables relatively few NLRs (ca. 150 in Arabidopsis) to cover 
a vast diversity of bacterial effectors (Jones et al. 2016). 
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How NLRs are activated mechanistically is still subject to debate. Generally, activation is 
thought to correlate with conformational changes and possibly via oligomerisation (Jones et 
al. 2016, Zhang et al. 2017). Our understanding of the events after NLR activation is more 
advanced. All TNLs, and certain CNLs, converge on the EDS1/PAD4 signalling hub. This 
protein complex functions as a signal relay positioned downstream of TNL activation, but 
upstream of transcriptional reprogramming (Wirthmueller et al. 2007, Garcia et al. 2010). 
Successful initiation of ETI includes various defence responses, among which pcd 
(programmed cell death), also known as HR (hypersensitivity response), and accumulation 
of SA are the most prominent ones. A simplified overview of PTI, ETI, and EDS1/PAD4 
positioning within immune signalling is depicted in Figure 1.1. 
 
 
Figure 1.1 Plant immune signalling. Simplified illustration of different layers of plant immunity. 
Pathogens are recognised by two mechanisms. Extracellular PRRs (pattern recognition receptors) 
detect conserved molecular patterns called PAMPs (pathogen-associated molecular patterns) and 
initiate a universal first immune response, PTI (pattern-triggered immunity). In the cytoplasm, 
secreted bacterial effectors counteract PTI, causing ETS (effector-triggered susceptibility). Adapted 
hosts in turn detect bacterial effectors via TNLs that convert on the signalling hub EDS1/PAD4. 
Upon nuclear localisation, EDS1/PAD4 heterodimer dependent transcriptional reprogramming 
occurs which results in SA accumulation and a sustained, pathogen specific immune response, ETI 
(effector-triggered immunity). 
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PTI and ETI were seen as processes employing distinct recognition and output machineries. 
In recent years however, evidence for interlaced immunity signalling between PTI and ETI 
has accumulated. Rather than quality, quantity seems to be the decisive factor between PTI 
and ETI. For instance genes that are differentially expressed during PTI and ETI overlap 
strongly, but vary in their abundance and timing (Tao et al. 2003). MAPK activation also 
suggests shared signalling components. During PTI, MPK3/6 activation is short-lived, but 
rapid. In presence of effectors though, MPK3/6 activation was sustained over several hours 
(Tsuda et al. 2013), suggesting context-specific adjustment of common signalling sets. 
Interestingly, successful PTI can partially suppress ETI, thereby limiting fitness costs for the 
plant (Hatsugai et al. 2017). In a recent review, Alhoraibi et al. discuss the distinct, but also 
the common features of PTI and ETI and propose a more interconnected relationship of the 
two immune responses (Alhoraibi et al. 2018). 
 
1.3 The EDS1/PAD4 signalling node 
EDS1 was identified in a forward genetic suppressor screen of Arabidopsis resistance 
against the oomycete Hyaloperonospora parasitica (Parker et al. 1996). Over time, EDS1 
has emerged as a major component of various aspects of plant immunity. In the following 
chapter I will summarise our current understanding of the EDS1 resistance node and the 
implications that arise from it. EDS1 is a nucleo-cytoplasmic protein with multi-facetted 
functions in plant immunity. It functions in basal (post-infection) and TNL-triggered 
immunity, but also in some CNL-triggered immune responses (Aarts et al. 1998, Rusterucci 
et al. 2001, Venugopal et al. 2009, Wang et al. 2009, Garcia et al. 2010, Makandar et al. 
2015, Cui et al. 2018). Further, SA dependent and SA independent roles have been shown 
(Glazebrook et al. 2003, Zhang et al. 2003, Bartsch et al. 2006, Gloggnitzer et al. 2014, Cui 
et al. 2016). 
1.3.1 Subcellular localisation determines EDS1 function  
EDS1 localisation depends on the cell’s immune status. In unchallenged tissues EDS1 
localises nucleo-cytoplasmically, while infection with avirulent Pseudomonas syringae pv. 
tomato DC3000 (hereinafter Pst) avrRPS4 causes EDS1 accumulation in the nucleus. This 
nuclear pool of EDS1 is essential for transcriptional reprogramming and resistance to 
bacterial and oomycete pathogens. Simultaneously, a cytoplasmic EDS1 fraction is 
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maintained and necessary for complete resistance (Garcia et al. 2010). Following this 
observation, distinct functions of nuclear and cytoplasmic EDS1 were found. While nuclear 
EDS1 steers transcriptional reprogramming to dampen bacterial growth, cytoplasmic EDS1 
elicits host cell death. This might allow the plant to fine-tune defence pathways for most 
efficient pathogen growth inhibition (Heidrich et al. 2011). Tight control of this nucleo-
cytoplasmic shuttling is crucial, as high levels of nuclear EDS1 cause DM2h 
(DANGEROUS MIX 2) dependent auto-immunity (Stuttmann et al. 2016). 
1.3.2 EDS1 and its signalling partners PAD4 and SAG101 constitute a 
unique plant protein family  
Genetic and molecular studies identified two signalling partners of EDS1, PAD4 
(PHYTOALEXIN-DEFICIENT 4) and SAG101 (SENESCENCE-ASSOCIATED GENE 
101) (Falk et al. 1999, Feys et al. 2001, Feys et al. 2005). Together these three proteins form 
a unique plant protein family with a N-terminal LP (lipase-like) domain with homology to 
α/β hydrolases (Ollis et al. 1992) and an unique C-terminal “EP” (EDS1-PAD4) domain 
with no known homologies (Feys et al. 2001, Feys et al. 2005, Wagner et al. 2013). EDS1 
and PAD4 contain a S-D-H catalytic triad common to lipase-like domains. Yet no enzymatic 
activity has been shown for EDS1, and catalytic triad mutants were fully functional in basal 
and TNL-triggered immunity, suggesting that EDS1 and PAD4 are not enzymatically active 
(Rietz et al. 2011, Wagner et al. 2013). SAG101 lacks the catalytic triad (Feys et al. 2005). 
With no catalytic activity of the LP domain and a previously unknown EP domain, 
mechanistic insights of the EDS1 protein family were difficult to gain.  
On a protein level, EDS1 forms exclusive heterodimers with PAD4 or SAG101, resulting in 
stabilisation of both interaction partners (Feys et al. 2001, Feys et al. 2005). Resolving the 
crystal structure of the EDS1/SAG101 heterodimer and subsequent modelling of the 
EDS1/PAD4 heterodimer provided crucial insights into the interaction mode of the three 
proteins (Wagner et al. 2013) (Figure 1.2). Heterodimer formation mainly relies on an 
interface of a hydrophobic EDS1 helix that fits into a corresponding pocket of SAG101, or 
PAD4, respectively. Mutation of several residues in the EDS1 hydrophobic helix (EDS1LLIF) 
abolishes interaction with SAG101, or PAD4, and renders EDS1 non-functional. Likewise, 
corresponding mutations in SAG101 (SAG101LLIY), or PAD4 (PAD4MLF) strongly, but not 
entirely, impair heterodimer formation (Wagner et al. 2013). Genetically, pathogen 
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challenged EDS1LLIF expressing plants resemble an eds1-2 null mutant, with 
hypersusceptibility to the oomycete Hpa (Hyaloperonospora arabidopsisdis). 
These features underline the importance of the EDS1/PAD4 or EDS1/SAG101 heterodimer 
in Arabidopsis immunity. SAG101 genetically partially compensates for loss of PAD4, 
suggesting similar signalling properties of the EDS1/PAD4 and the EDS1/SAG101 
heterodimer. However, SAG101 localises exclusively to the nucleus, while PAD4 is present 
nucleo-cytoplasmically, suggesting potential functional distinction (Feys et al. 2005, 
Wagner et al. 2013). Recent work in our group supports distinct roles of PAD4 and SAG101 
in plant immunity. While the TNL-activated EDS1/SAG101 heterodimer promotes cell 
death, the TNL-activated EDS1/PAD4 heterodimer limits bacterial growth (Lapin et al., 
submitted). 
 
 
Figure 1.2 Crystal structure of the EDS1/SAG101 heterodimer. Both proteins contain a lipase-
like domain (EDS1: light blue, SAG101: yellow) and the family specific EP domain (EDS1: light 
purple, SAG101: green). EDS1 contains a conserved S-D-H triad typical for lipases. Taken from 
Wagner et al. 2013 
 
Further, Wagner et al. (2013) showed that both the LP and EP domains are necessary for full 
EDS1 resistance signalling and while the LP domain is stable by itself, the EP domain relies 
on stabilisation by the LP domain. Together with the fact that heterodimer formation 
depends on residues in the LP domain, and the absence of catalytic activity, this suggests a 
scaffolding function of the LP domain and a signalling function of the EP domain. This is in 
line with recent work in the group which established a specific role of the EP domain within 
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an EDS1/PAD4 heterodimer in timely reprogramming of the Arabidopsis immune response 
(Bhandari et al. 2019). 
1.3.3 EDS1/PAD4 control SA dependent and SA independent pathways 
The characterisation of EDS1/PAD4 proteins revealed that the EDS1/PAD4 complex signals 
upstream of SA in both basal and TNL-triggered immunity with EDS1/PAD4 supporting SA 
accumulation (Zhou et al. 1998, Jirage et al. 1999, Feys et al. 2001). On the other hand, 
exogenous application of SA enhances transcript and protein levels of EDS1 and PAD4, 
supporting the idea of an EDS1/PAD4 - SA positive feedback loop which fortifies SA 
dependent resistance signalling (Jirage et al. 1999, Feys et al. 2001). 
Adding another layer of complexity to this signalling network, EDS1/PAD4 also employ SA 
independent pathways for resistance signalling (Li et al. 2001, Zhang et al. 2003, Bartsch et 
al. 2006). Recently, our group disentangled these SA dependent and SA independent 
processes. My colleagues showed that overexpressed EDS1 and PAD4 act in parallel with 
SA signalling and protect the SA pathway from pathogenic or genetic perturbations (Cui et 
al. 2016). For this, EDS1 and PAD4 engage hormone crosstalk. Specifically, TNL-activated 
EDS1/PAD4 shelter SA signalling from JA antagonism by interfering with the JA master TF 
MYC2 (Cui et al. 2018). This exemplifies a characteristic of ETI which protects crucial 
defence sectors like the SA node to ensure robust resistance signalling. The EDS1/PAD4 
compensatory mechanism fits with the notion of network buffering where interactions 
within the immune signalling network constitute a robust and dynamic defence response 
(Cui et al. 2016, Hillmer et al. 2017). 
Hormone crosstalk regulation presents a new function of the EDS1/PAD4 complex and will 
be addressed in more detail in this study. In summary, the EDS1 regulatory node allows the 
plant to respond to multi-facetted immune challenges in an effective and efficient manner by 
prioritising and integrating signalling pathways.  
 
1.4 SA signalling  
The role of SA in plant defence is rather well understood. SA is typically associated with 
resistance against microbial biotrophic pathogens (Glazebrook 2005). Chemically, SA is a 
phenolic acid and is predominantly synthesised via ICS1 (ISOCHORISMATE SYNTHASE 
1) (Wildermuth et al. 2001). Upon pathogen attack SA levels increase significantly, with 
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EDS1 and PAD4 mediating TNL-triggered immune responses (Wiermer et al. 2005) and the 
resistance protein NDR1 (NON RACE-SPECIFIC DISEASE RESISTANCE 1) mediating 
CNL-triggered signalling (Aarts et al. 1998). Once SA accumulates, it initiates relocalisation 
of NPR1 (NON-EXPRESSOR OF PR GENES 1), which in the absence of SA forms 
oligomers in the cytoplasm. SA induced changes in the cell’s redox state promote NPR1 
monomerisation and translocation into the nucleus where it acts as a co-activator of defence 
genes (Tada et al. 2008). The underlying mechanism is well understood. Within the nucleus, 
NPR1 binds to and activates TGA TFs (members of the bZIP TF family) that sit at the 
promoter of SA-responsive genes like PR1 (PATHOGENESIS-RELATED GENE 1) or 
WRKYs (Despres et al. 2000, Eulgem et al. 2007). To restrict SA signalling NPR1 is 
phosphorylated and subjected to 26S proteasomal degradation (Spoel et al. 2009).  
The nature of the SA receptor has been a long-standing matter of debate in the scientific 
community. While NPR1 acts as the SA signal transducer (Dong 2004, Yan et al. 2014), 
opposing views on the SA binding capabilities of NPR1 exist. In 2012 the NPR1 paralogues 
NPR3/NPR4 were shown to bind SA with different affinities (Fu et al. 2012) and in the 
same year, NPR1 was proposed to be the SA receptor (Wu et al. 2012). More recently, both 
NPR1 and NPR3/NPR4 were described as SA receptors, but with opposing roles in 
transcriptional reprogramming during plant immunity (Ding et al. 2018). The perception of 
SA by multiple, non-redundant receptors is unique in the plant hormone network and 
explains the seemingly controversial observations in the search for a SA receptor. 
 
1.5 The core JA pathway  
Besides SA, JA is of exceptional importance for plant defence. Analogous to SA repressing 
biotrophic microbes, JA primarily antagonises necrotrophic pathogens (Glazebrook 2005). 
The starting point for JA biosynthesis are fatty acid precursors, which are processed via 
multiple biochemical reactions to JA. “JA” is usually used as a generic term that spans a 
broad spectrum of JA metabolites. These can be conjugated and modified in multiple ways, 
resulting in JA derivatives with diverse functions. Generally, the conjugate jasmonoyl 
isoleucine (JA-Ile) is the predominant biologically active compound (Wasternack 2007, 
Wasternack et al. 2013). Interestingly, plant pathogens like Pst have evolved functional 
mimics of JA-Ile such as COR (coronatine) (Mittal et al. 1995, Brooks et al. 2004). COR is a 
small molecule that competes with JA-Ile to activate the JA pathway. Initiation of JA 
signalling antagonises SA dependent immunity and enhances Pst virulence (Brooks et al. 
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2004, Brooks et al. 2005, Zheng et al. 2012). JA signalling relies on the repression of 
repressors. Molecularly, this means that key JA TFs are kept inactive by a family of 
repressor proteins, the so-called JAZ (JASMONATE ZIM DOMAIN) proteins (Chini et al. 
2007, Thines et al. 2007). Together with the co-repressors NINJA (NOVEL INTERACTOR 
OF JAZ) and TPL (TOPLESS) JAZ proteins keep the JA pathway in check (Pauwels et al. 
2010).  
Active JA-Ile is bound by COI1 (CORONATINE-INSENSITIVE 1), an E3 ubiquitin-ligase 
that is part of the SKP1-Cullin-F-box complex SCFCOI1, which leads to ubiquitin dependent 
proteasomal degradation of JAZ proteins (Sheard et al. 2010). The removal of JAZ proteins 
sets key JA TFs free. JA signalling can be divided in two branches: the MYC 
(MYELOCYTOMATOSIS ONCOGENE HOMOLOG) branch (Lorenzo et al. 2004, 
Dombrecht et al. 2007) and the ERF (ETHYLENE RESPONSE FACTOR) branch (Lorenzo 
et al. 2003, Pre et al. 2008). The MYC branch is controlled by MYC class IIIe bHLH (basic 
helix-loop-helix) TFs, with its most prominent members being MYC2/3/4. Well-known 
marker genes of this branch are VSP1/2 (VEGETATIVE STORAGE PROTEIN 1/2) and 
LOX3 (LIPOXYGENASE 3) for instance. The ERF branch on the other hand is regulated by 
AP2/ERF (APETALA2/ETHYLENE RESPONSE FACTOR) TFs. Typical genes regulated 
by this branch are PDF1.2 (PLANT DEFENSIN 1.2) or ORA59 (OCTADECANOID-
RESPONSIVE ARABIDOPSIS 59). Interestingly, ERF branch genes can be repressed by 
MYC2 (Zhai et al. 2013). On contrast to the MYC branch, activation of the ERF branch 
involves the plant hormone ethylene and is more complex and less well understood (Lorenzo 
et al. 2003, Pre et al. 2008). Functionally, the two pathways are thought to differ in their 
responsiveness to different attackers. The MYC pathway is activated by wounding and 
herbivorous damage (Lorenzo et al. 2004, Kazan et al. 2013), while microbial necrotrophic 
pathogens activate the ERF branch (Berrocal-Lobo et al. 2002, Lorenzo et al. 2003). A 
simplified overview of JA signalling is depicted in Figure 1.3. 
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Figure 1.3 Scheme of JA signalling in context of plant immunity. In absence of JA the JA master 
TF MYC2 is repressed by the JAZ protein family. JA or its bacteria derived functional mimic COR 
lead to COI1 dependent proteasomal JAZ degradation, thereby releasing MYC2 and activating 
MYC2 specific gene expression. Generally, MYC2 activation correlates with decreased resistance to 
biotrophic pathogens and increased resistance to necrotrophic ones. 
 
1.5.1 The JAZ protein family represses JA signalling 
Since JA signalling needs to be tightly regulated, diverse (auto-)regulatory mechanisms have 
been observed. For instance, JA biosynthesis is promoted by JA itself, ensuring a robust JA 
response when necessary. Further downstream in the signalling cascade MYC2 restricts its 
own transcription twofold: i) by binding a G-box motif in its own promoter, and ii) by 
rapidly inducing JAZ transcription (Chini et al. 2007, Dombrecht et al. 2007). Besides this 
transcriptional regulation, an additional auto-regulatory MYC2 mechanism has been 
described. Once activated, MYC2 promotes the MTB (MYC2-TARGETED BHLH) 
proteins, a small subgroup of bHLH proteins. MTBs compete with MYC2 for binding of 
MED25 (MEDIATOR 25), a transcriptional co-activator of MYC2, thereby attenuating 
MYC2 transactivation activity (Liu et al. 2019).  
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The probably most dynamic and versatile tool to fine-tune JA signalling are the JAZ 
repressor proteins. 13 JAZs have been identified so far (Chini et al. 2016) and while the 
majority seems to act redundantly, there are gradually more insights gained into functional 
specification of single JAZ proteins. Common to all JAZs is their transcriptional regulation. 
In presence of JA, JAZ proteins are degraded by the 26S proteasome, thus releasing their 
target genes. At the same time, JAZ transcription is enhanced which allows a quick 
replenishment of JAZ proteins if necessary (Chini et al. 2007, Pauwels et al. 2011). JAZ 
specificity is accomplished by different means, for instance JAZ1/2/5-10 are highly up 
regulated after Pst infection (Demianski et al. 2012). Yet only jaz10 mutants show 
hypersusceptibility to Pst (Demianski et al. 2012). This was further supported by the finding 
that JAZ10 acts synergistically with JAZ5 in restricting COR cytotoxicity, as jaz10/jaz5 
double mutants showed enhanced chlorosis in Pst infected leaves (de Torres Zabala et al. 
2016). JAZ6 takes part in circadian regulation of plant defence against Botrytis cinerea. 
Arabidopsis is more susceptible to B. cinerea during the night, than at dawn. However, jaz6 
mutant plants lose this daytime dependent susceptibility, indicating a specific role for JAZ6 
in this context (Ingle et al. 2015). JAZ2 localises exclusively to guard cells and mediates 
COR induced stomatal re-opening (Gimenez-Ibanez et al. 2017) and JAZ4/7/8 have been 
identified as important components of JA-induced leaf senescence (Jiang et al. 2014, Yu et 
al. 2016). Finally, JAZ3 interacts with the bacterial effector HopBB1 leading to degradation 
of the JA pathway repressor TCP14 and promotion of bacterial virulence (Yang et al. 2017).  
To extend the regulatory repertoire of JAZ proteins they are able to form homo- and 
heteromers within the JAZ family, but we are still missing a detailed understanding of the 
functional implementations this has (Chini et al. 2009, Chung et al. 2009). The diversity of 
JAZ proteins also helps to re-suppress JA signalling and avoids hyperactivation. Means to 
accomplish this are specific JAZ degrons and alternative splice variants. JAZ8 for instance 
lacks the typical COI1 recognition motif that mediates COI1-JAZ binding and is therefore 
less prone to COI1 dependent proteasomal degradation (Shyu et al. 2012). A similar 
observation has been made for JAZ13 (Thireault et al. 2015). To increase the regulatory 
range even further, alternative splice variants of certain JAZ proteins have been described in 
context of re-suppressing JA signalling. A well-known example is JAZ10, which exists in 
three isoforms. The shortest of these isoforms (JAZ10.4) lacks the Jas domain that is 
necessary for COI1 binding and subsequent degradation (Chung et al. 2009). Consistent 
with this, JAZ10.4 did not bind COI1, even in presence of high (200 µM) COR. Other tested 
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interactions including MYC2 and several JAZs were unchanged, suggesting a specific COI1 
related function. Overexpressing this variant led to coi1 like hyposensitivity to JA and 
associated elongated root length and impaired seed set phenotypes (Chung et al. 2009, 
Chung et al. 2010). This dominant-negative effect has been also observed in other JAZ 
proteins and supports the notion that alternatively spliced JAZ proteins that evade COI1 
mediated degradation keep activated JA signalling in check (Chung et al. 2010).  
1.5.2 MYC2 is the master TF in JA signalling 
As mentioned, a large number of JA outputs rely on the bHLH TF MYC2 (Kazan et al. 
2013). MYC2 function is largely, but not exclusively, redundant with MYC3 and MYC4. 
For instance, MYC3 and MYC4 act additively to MYC2 in transducing JA signalling 
(Fernandez-Calvo et al. 2011) and in driving gene expression for producing glucosinolates 
to restrict insect feeding (Schweizer et al. 2013). Recent work from our group shows that 
MYC2/3/4 also act additively in antagonising expression of EDS1 (Qiu et al., in prep.). The 
high redundancy again raises the question of functional and regulatory specificity. Part of 
the answer might lie in the spatio-temporal expression of these proteins. While MYC2 
transcript is found predominantly in the root, MYC3 and MYC4 mRNAs are present in the 
aerial parts of the plant (Fernandez-Calvo et al. 2011, Gasperini et al. 2015). MYC5, a less 
regarded member of the MYC family, localises exclusively to the stamen where it acts 
together with MYC2/3/4 in stamen development (Qi et al. 2015). Temporally, MYC2 
accumulation correlates with circadian clock connecting time-of-day regulation with the JA 
pathway (Shin et al. 2012). MYC2/3/4 homo- and heterodimerise with each other and 
interact with nearly all JAZ proteins, indicating that signalling specificity is not achieved via 
distinct protein interaction (Fernandez-Calvo et al. 2011, Chini et al. 2016). 
A major step forward in understanding how JAZ proteins repress MYC was the successful 
crystallisation the JAZ9/MYC3 complex. When bound to JAZ9, MYC3 undergoes 
substantial conformational changes and, consequently, cannot interact with its 
transcriptional activator MED25. Thus, JAZ9/MYC3 interaction provides a molecular 
switch that allows changing between transcriptional repression and activation (Zhang et al. 
2015).  
For a detailed discussion of SA-JA crosstalk during plant immunity please refer to chapter 
3.3. 
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1.6 Thesis aims 
In an evolutionary arms race plants have evolved sophisticated defence mechanisms against 
a plethora of pathogens. In turn, pathogens have evolved strategies to maintain and/or 
enhance their virulence. In this context, the EDS1 signalling node represents a central 
convergence point for basal and TNL-triggered immunity which acts in signal relay between 
activated NLRs and the transcriptional reprogramming machinery. Despite new mechanistic 
insights, our understanding of how EDS1 family proteins ensure a robust and strong immune 
response remains limited. 
Antagonistic crosstalk between SA and JA is well established and distinct roles for SA and 
JA have been identified in context of plant immunity (Robert-Seilaniantz et al. 2011, 
Pieterse et al. 2012, Thaler et al. 2012). Recent work in our group revealed a molecular basis 
for this antagonism that connects EDS1 to the JA master TF MYC2. MYC2 was found to 
interact with all EDS1 family proteins and to repress EDS1 promoter activity, leading to 
enhanced COR dependent Pst virulence (Cui et al. 2018, Qiu et al., in prep.). Similarly, we 
could show that during ETI, EDS1 represses MYC2 outputs, thus attenuating COR 
dependent virulence and reinforcing SA dependent defence (Cui et al. 2018). These data 
reveal that a central immune node intervenes with hormone crosstalk.  
I started this work knowing that EDS1 and MYC2 were functionally connected. However, 
the nature of this relationship and its molecular basis were unclear. I decided to focus on 
EDS1 and its regulation of MYC2 and divided my approach in two parts. First, I tested 
systematically if EDS1 family members altered MYC2 accumulation on protein and 
transcript levels and if so, how this affected MYC2 transactivation activity. Second, I aimed 
to identify and functionally characterise the mechanism(s) by which EDS1 regulates MYC2 
activity. Specifically, I analysed MYC2 regulation by repressor proteins and MYC2 PTMs 
(post-translational modifications). 
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2 Results 
This thesis is divided into two sections. Section 2.1 addresses if and how the EDS1 protein 
family impacts MYC2 transcript, protein, and target genes. To test this, I first characterised 
and then employed the Arabidopsis mesophyll protoplast system to probe MYC2 mRNA 
and protein levels when co-expressed with EDS1, PAD4, and/or SAG101. To test 
correlation of MYC2 abundance with its transactivation activity I tested MYC2 regulated 
genes. 
The aim of section 2.2 was to find a mechanistic explanation for EDS1/PAD4 dependent 
MYC2 regulation. To this end I analysed MYC2 dimerisation properties, JAZ proteins, and 
MYC2 post-translational modifications. 
 
2.1 Impact of EDS1 family proteins on MYC2 abundance and 
transactivation activity 
2.1.1 Arabidopsis protoplasts are responsive to avrRPS4 and COR 
Previous work in the group had shown that EDS1, PAD4, and SAG101 can interact with 
MYC2 in vitro (Cui et al. 2018). To assess whether EDS1 family proteins modify MYC2 
abundance, i.e. transcript and/or protein accumulation I decided to use the established 
Arabidopsis protoplast system used in our group, which is based on the protocol published 
by the Sheen group (Yoo et al. 2007). The advantages of using this system are i) relatively 
high sample number with results in short time, ii) use of protoplasts of specific genetic 
background, and iii) intact Arabidopsis cell signalling in isolated cells. Figure 2.1A shows a 
simplified workflow of protoplast isolation. Inevitably, the isolation procedure stresses cells 
and might alter cell signalling in unexpected ways. Therefore, I first tested whether 
protoplasts are still able to induce a defence response by transforming the bacterial effector 
protein avrRPS4 into eds1-2/pad4-1/sag101-2 (hereinafter called eps) cells. Upon infection, 
Pst avrRPS4 triggers EDS1/PAD4 dependent ETI as shown by induction of marker genes 
such as ICS1 and PBS3. Co-expression of EDS1-YFP, PAD4-YFP and avrRPS4-HA 
induced ICS1 and PBS3 significantly, while EDS1 and PAD4 alone, or together with the 
inactive effector variant avrRPS4KRVY (Sohn et al. 2009) did not (Figure 2.1B). 
Results 
 
 16 
Consequently, isolated cells induce ETI-like signalling upon transient gene expression 
making the protoplast system a potent mimic of in planta conditions. To ensure similar 
transformation efficiency I adjusted the transformed plasmid volumes if necessary with 
“neutral” 35S:GUS plasmid between samples. 
 
 
Figure 2.1 Protoplast isolation and characterisation. 
(A) Schematic workflow of protoplast isolation from Arabidopsis leaves. 3 - 4 leaves from healthy, 
4-week-old plants were cut with a scalpel, digested with cellulase and macerozyme, filtered, washed 
and transformed via PEG to obtain transiently transformed cells.  
(B) eps protoplasts initiate ETI-like signalling if transformed with EDS1-YFP, PAD4-flag, and 
avrRPS4-HA, but not if transformed with EDS1-YFP and PAD4-flag alone, or with inactive 
avrRPS4KRVY-HA. RNA was extracted 14 h after eps protoplast transformation. Relative transcript of 
ICS1 and PBS3 was determined by qRT-PCR and normalised to ACTIN2. Asterisks indicate 
statistical difference (mixed linear model, adjusted p-value≤0.001). Error bars represent normalised 
mean standard error. Data from three independent experiments.  
(C) WT and eps protoplasts respond to 2 µM COR treatment. myc234 protoplasts served as negative 
control. -COR are MOCK (DMSO) treated samples. RNA was extracted 16 h after isolation with 2 h 
2 µM COR treatment preceding harvesting. Relative transcript of LOX3 and MYC2 was determined 
by qRT-PCR and normalised to ACTIN2. Asterisks indicate statistical difference (mixed linear 
model, adjusted p-value≤0.001). Error bars represent normalised mean standard error. Data from 
three independent experiments. ns: not significant 
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Since protoplast isolation exerts physical stress on cells I wanted to assess if protoplasts are 
still responsive to exogenous JA stimulation, i.e. addition of COR. To address this, I tested 
JA marker gene expression of LOX3 and MYC2 with or without COR application in WT, 
eps, and myc234 protoplasts. 2 h treatment with 2 µM COR significantly induced LOX3 and 
MYC2 expression in WT and eps cells, but not in myc234 (Figure 2.1C) demonstrating that 
protoplasts are responsive to COR treatment. 
In summary, the obtained protoplasts induce ETI-like gene expression and react to COR 
treatment suggesting that the endogenous cell signalling network is intact and responsive. 
2.1.2 PAD4 and SAG101, but not EDS1 increase MYC2 protein level 
While all EDS1 family proteins interact with MYC2, the interaction of PAD4 or SAG101 
with MYC2 is seemingly stronger than with EDS1 (Cui et al. 2018). To test effects of EDS1, 
PAD4, and SAG101 on basal MYC2 protein level I co-expressed SH-MYC2 with EDS1-
flag, PAD4-YFP, or SAG101-YFP respectively and visualised protein amounts via 
immunoblotting. In presence of EDS1, MYC2 protein level was similar to a YFP control 
sample. Interestingly, in presence of PAD4 or SAG101 MYC2 was clearly more abundant 
(Figure 2.2A). This observation cannot be explained by transcript level, as native MYC2 
transcript was not affected by expressing YFP, EDS1-flag, PAD4-YFP, SAG101-YFP, 
EDS1-flag with PAD4-YFP, or EDS1LLIF-flag, a heterodimerisation-deficient version with 
PAD4-YFP (Figure 2.2B). This suggests a post-translational effect of PAD4 and SAG101 
on MYC2. 
In context of ETI the formation of an EDS1/PAD4 heterodimer is necessary for intact 
defence signalling (Feys et al. 2001, Wagner et al. 2013). SAG101 has been shown to act 
largely redundantly with PAD4 (Feys et al. 2005) which is why the following experiments 
include PAD4, but not SAG101. So far, little is known about functions of EDS1, PAD4, 
(and SAG101) as monomers. This prompted me to test MYC2 protein levels in presence of 
the EDS1/PAD4 heterodimer in immune non-challenged (without avrRPS4) and immune 
challenged (with avrRPS4) cells. Co-expressing PAD4-YFP with EDS1-flag abolished the 
PAD4 promoting effect on MYC2 abundance while this was not the case with EDS1LLIF-flag 
(Figure 2.2C), suggesting that heterodimer formation affects MYC2 protein accumulation. 
The addition of avrRPS4-HA had no effect (Figure 2.2C). 
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I conclude that PAD4 (and SAG101) stabilise MYC2 on protein level and that this 
stabilisation is impaired by EDS1/PAD4 heterodimer formation. This seems to be 
independent of the immune status of the cell, as this was observed in avrRPS4 expressing 
and non-expressing samples. 
 
  
Figure 2.2 PAD4 and SAG101 stabilise 
MYC2 protein but not MYC2 transcript. 
(A) SH-MYC2 protein accumulation in eps 
protoplasts co-expressed with EDS1-flag, 
PAD4-YFP, or SAG101-YFP 14 h after 
transformation. YFP served as control. Note 
how PAD4 and SAG101, but not ESD1 
stabilise MYC2. 
(B) Native MYC2 transcript is unchanged by 
transient expression of EDS1 family proteins. 
Relative transcript of MYC2 was determined by 
qRT-PCR normalised to ACTIN2. Different 
letters indicate statistically significant 
differences (mixed linear model, adjusted p-
value≤0.01). Error bars represent normalised 
mean standard error. Data from two 
independent experiments. 
(C) EDS1-PAD4 heterodimer formation 
abolishes PAD4 stabilisation of MYC2. SH-
MYC2 protein accumulation in eps protoplasts 
co-expressed with EDS1-flag and PAD4-YFP 
or EDS1LLIF-flag and PAD4-YFP. AvrRPS4-
HA did not affect this.  
(A,C) Ponceau-S staining shows equal sample 
loading. Experiments were repeated three times 
with similar results. SH: StrepII-3xHA. 
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2.1.3 PAD4 does not stabilise MYC2 via 26S proteasome or JAZ 
inhibition 
To find a mechanistic explanation for the observed MYC2 levels I interrogated the role of 
the 26S proteasome. MYC2 is under strict control of the 26S proteasome and proteasome 
inhibition stabilizes MYC2 protein (Shin et al. 2012, Zhai et al. 2013, Jung et al. 2015). 
Thus, a simple explanation for high MYC2 amounts would be PAD4 protecting MYC2 from 
proteasomal degradation. As before, I expressed SH-MYC2 with PAD4-YFP, with PAD4-
YFP and EDS1-flag, or with PAD4-YFP and EDS1LLIF-flag, but added 50 µM MG132, a 
potent proteasome inhibitor. MG132 increased overall MYC2 levels, yet PAD4 still 
enhanced MYC2 abundance and addition of EDS1 counteracted this (Figure 2.3A). Thus, 
the observed MYC2 amounts are unlikely to be caused by changed 26S proteasome activity. 
 
Figure 2.3 PAD4 does not stabilise MYC2 via 26S proteasome or JAZ protein regulation. 
(A) SH-MYC2 protein accumulation in eps protoplasts co-expressed with PAD4-YFP, PAD4-YFP 
and EDS1-flag, or PAD4-YFP and EDS1LLIF-flag, 14 h after transformation. YFP served as control. 
Addition of 50 µM MG132 (2 h) enhanced overall MYC2 protein levels, but did not change MYC2 
stabilisation by PAD4 and EDS1 inhibition. 
(B) EDS1/PAD4 dependent MYC2s accumulation pattern resembles MYC2WT. 
(A,B) Ponceau-S staining shows equal sample loading. Experiments were repeated three times. SH: 
StrepII-3xHA. 
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Besides the 26S proteasome, JAZ proteins are well-known regulators of MYC2 (Chini et al. 
2007, Kazan et al. 2013, Zhang et al. 2015). The single amino acid change D105N releases 
MYC2 form JAZ suppression and results in a gain-of-function MYC2 referred to as “super-
MYC2”, (MYC2s) (Goossens et al. 2015). If PAD4 and/or EDS1 interfered with MYC2-
JAZ regulation this JAZ-uncoupled MYC2 variant should behave different to MYC2WT. 
Similar to MG132 treated samples, SH-MYC2s samples showed elevated MYC2 levels, yet 
the observed abundance pattern for MYC2WT was unchanged when co-expressed with 
various EDS1/PAD4 combinations (Figure 2.3B). The different MYC2 amounts can 
therefore not be explained by regulation of JAZ proteins. This means that quantity, but not 
quality of MYC2 accumulation depends on 26S proteasome and JAZ proteins. 
2.1.4 EDS1 enhances MYC2 transactivation activity 
Since MYC2 is a transcription factor mere transcript or protein abundance are of limited 
information when it comes to functional implications. Even very low levels of a TF can be 
biologically active (Cheng et al. 2007). To address this I used a transactivation assay in eps 
protoplasts that measures MYC2 activity. MYC2 activates expression of LOX3 and VSP1 
and represses expression of ORA59 (Lorenzo et al. 2004, Verhage et al. 2011). By adding 
SH-MYC2 alone or with EDS1-flag, PAD4-YFP, or EDS1-flag with PAD4-YFP I tested 
whether MYC2 activity was changed EDS1/PAD4 dependently. Compared to YFP, SH-
MYC2 induced LOX3 and VSP1 levels and decreased ORA59 levels providing functional 
proof for the assay. Intriguingly, co-expression of EDS1-flag and SH-MYC2 significantly 
increased LOX3 and VSP1 levels compared to YFP and SH-MYC2 suggesting a promoting 
effect of EDS1 on MYC2 (Figure 2.4A,B). This stimulation was not observed by co-
expressing PAD4-YFP, or EDS1-flag with PAD4-YFP indicating an EDS1 specific feature, 
which is abolished by PAD4. EDS1 also enhanced the repressive function of MYC2 on 
ORA59, yet to similar levels as PAD4 or EDS1 with PAD4 did (Figure 2.4C). The results for 
ORA59 are therefore less clear and should be interpreted with caution.  
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Figure 2.4 EDS1 promotes MYC2 transactivation activity. 
MYC2 transactivation activity assay via qRT-PCR. SH-MYC2 was expressed separately, or together 
with YFP, EDS1-flag, PAD4-YFP, or EDS1-flag plus PAD4-YFP and LOX3 (A), VSP1 (B), and 
ORA59 (C) transcript was measured 14 h after eps protoplast transformation. Different letters 
indicate statistically significant differences (mixed linear model, adjusted p-value<0.01 (A), adjusted 
p-value≤0.05 (B and C)). Error bars represent normalised mean standard error. Data from four 
independent experiments. (D) Immunoblot confirming expression of proteins in samples of (A-C). 
Ponceau-S staining shows equal sample loading. Note that high MYC2 transactivation activity in 
EDS1 co-expressed samples does not correlate with high MYC2 protein amounts. SH: StrepII-
3xHA. 
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Testing protein accumulation confirmed proper protein expression showing that the 
observed changes in MYC2 transactivation activity are not due to protein amounts (Figure 
2.4D).  
Overall, this data demonstrates an EDS1 specific, positive function on MYC2 activity and is 
in contrast to the observed protein abundance described in Figure 2.2A were MYC2 was 
most abundant when co-expressed with PAD4. Consequently, MYC2 protein abundance and 
transactivation activity do not correlate, suggesting post-translational regulation. 
2.1.5 EDS1 does not enhance MYC2s transactivation activity 
EDS1 could promote MYC2 activity by releasing it from JAZ suppression. To test this 
hypothesis I co-expressed YFP, EDS1-flag, PAD4-YFP, or EDS1-flag with PAD4-YFP with 
SH-MYC2WT or with SH-MYC2s. While EDS1 enhanced LOX3 and VSP1 levels when co-
expressed with MYC2WT, it failed to do so when co-expressed with MYC2s. Consistent with 
the previous experiment, PAD4 and EDS1 with PAD4 did not affect expression (Figure 
2.5A,B). ORA59 was not tested. As EDS1 could not promote the activity of a JAZ 
uncoupled MYC2 this indicates that EDS1 releases MYC2 from JAZ suppression. 
Interestingly, VSP1 expression was higher in all MYC2s samples compared to MYC2WT 
samples which is in line with a JAZ uncoupled MYC2. However, this was not true for 
LOX3, as expression was similar between MYC2s and MYC2WT. This suggests different 
regulatory pathways.  
To rule that the absence of EDS1 promotion on MYC2s was due to a lack of protein, I 
verified protein levels for all transformed constructs, i.e. YFP, EDS1-flag, PAD4-YFP, SH-
MYC2WT and SH-MYC2s. In short, all constructs are expressed well and MYC2s is more 
stable than MYC2WT (Figure 2.5C). Again, protein amount does not correlate with 
transactivation activity and is therefore not indicative of functional impact. 
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Figure 2.5 EDS1 does not promote MYC2s transactivation activity. 
MYC2 transactivation activity assay via qRT-PCR. SH-MYC2 or SH-MYC2s was transformed with 
YFP, EDS1-flag, PAD4-YFP, or EDS1-flag plus PAD4-YFP and LOX3 (A) and VSP1 (B) transcript 
was measured 14 h after eps protoplast transformation. Note the overall enhanced VSP1 levels in 
MYC2s samples. Different letters indicate statistically significant differences (mixed linear model, 
adjusted p-value≤0.05). Error bars represent normalised mean standard error. Data from three 
independent experiments. (C) Immunoblot confirming expression of proteins in samples of (A) and 
(B). Ponceau-S staining shows equal sample loading. SH: StrepII-3xHA. 
 
2.1.6 MYC2s interacts with EDS1 family proteins 
With MYC2s not being promoted by EDS1 I hypothesised that MYC2s might not interact 
with EDS1. To test this I expressed SH-MYC2WT and SH-MYC2s in eps protoplasts together 
with YFP, EDS1-YFP, PAD4-YFP, SAG101-YFP, or EDS1-flag with PAD4-YFP. As 
reported earlier (Cui et al. 2018), MYC2WT co-immunoprecipitated (co-IPed) with all EDS1 
family proteins. Interestingly, MYC2s showed similar, yet weaker interaction (Figure 2.6).  
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Figure 2.6 MYC2s retains interaction with EDS1 family proteins. 
Co-IP analysis of EDS1-YFP, PAD4-YFP, SAG101-YFP or PAD4-YFP plus EDS1-flag co-
expressed with SH-MYC2 or SH-MYC2s 14 h after transformation of eps protoplasts. GFP trap IP 
shows that MYC2s retains interaction with EDS1 family proteins, but with weaker intensity than 
MYC2WT. YFP served as control. Ponceau-S staining shows equal sample loading. SH: StrepII-
3xHA. Performed thrice with similar results.  
 
This is remarkable, as MYC2s is more stable than MYC2WT (see input), but co-IPs less, 
suggesting that the MYC2D105N mutation affects MYC2-EDS1 interaction. Still, interaction 
is clear and is unlikely to be the cause for the lack of EDS1 dependent MYC2s promotion. 
 
2.1.7 AvrRPS4 abolishes the EDS1 promoting effect on MYC2 
transactivation activity 
Given the well-established SA/JA antagonism it was unexpected to find EDS1 promoting 
MYC2. Further, this is a rare case where EDS1 functions as a monomer and not in context 
of an EDS1/PAD4 heterodimer. This led me to test whether the results I obtained in 
pathogen unchallenged conditions were consistent in ETI-like conditions. Adding avrRPS4-
HA to the previously described experiment indeed abolished EDS1 promotion of MYC2 
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transactivation activity (Figure 2.7A,B). As these experiments were done in eps protoplasts, 
only the last sample contains EDS1 and PAD4, i.e. the functional EDS1/PAD4 heterodimer, 
which is crucial for ETI signalling after avrRPS4 recognition. The fact that avrRPS4 
changes MYC2 output in samples containing EDS1 alone indicates that avrRPS4 affects the 
EDS1-MYC2 relationship independent of EDS1/PAD4 dependent dimerisation and 
canonical ETI signalling. Again, I verified protein expression to ensure the lack of 
transactivation activity was not due to lack of protein (Figure 2.7C).  
   
Figure 2.7 AvrRPS4 abolishes the EDS1 promoting effect on MYC2. 
MYC2 transactivation activity assay via qRT-PCR. SH-MYC2 and avrRPS4-HA were co-expressed 
with YFP, EDS1-flag, PAD4-YFP, or EDS1-flag plus PAD4-YFP and LOX3 (A) and VSP1 (B) 
transcript was measured 14 h after eps protoplast transformation. YFP alone served as control. Note 
how in the presence of avrRPS4, EDS1 does not promote MYC2 transactivation activity. Further, 
MYC2 induced LOX3 transcript, but not VSP1 transcript. Different letters indicate statistically 
significant differences (mixed linear model, adjusted p-value≤0.05). Error bars represent normalised 
mean standard error. Data from three independent experiments. (C) Immunoblot confirming 
expression of proteins in samples of (A) and (B). Ponceau-S staining shows equal sample loading. 
Note that MYC2 transactivation activity does not correlate with high MYC2 protein amounts. SH: 
StrepII-3xHA. 
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2.1.8 EDS1 does not promote other TF classes 
With EDS1 positively regulating MYC2 I wondered if this is specific to MYC2. Therefore I 
tested the effect of EDS1 on PIF4 (PHYTOCHROME INTERACTING FACTOR 4), like 
MYC2 a bHLH TF, which has not been described in EDS1 dependent immune signalling. 
IAA19 is positively regulated by PIF4 and was used as a readout in this assay (Sun et al. 
2013). Surprisingly, EDS1 also promoted PIF4 activity resulting in increased IAA19 levels 
(Figure 2.8A).  
 
 
Figure 2.8 EDS1 promotes PIF4, but not SOC1 or MYB33 transcription activities. 
(A) qRT-PCR analysis of SH-PIF4 co-expressed with YFP, EDS1-flag, PAD4-YFP, or EDS1-flag 
plus PAD4-YFP. IAA19 transcript was measured 14 h after eps protoplast transformation. 
(B) qRT-PCR analysis of SH-SOC1 co-expressed with YFP, EDS1-flag, PAD4-YFP, or EDS1-flag 
plus PAD4-YFP. AP1 transcript was measured 14 h after eps protoplast transformation.  
(C) qRT-PCR analysis of SH-MYB33 co-expressed with YFP, EDS1-flag, PAD4-YFP, or EDS1-
flag plus PAD4-YFP. LFY transcript was measured 14 h after eps protoplast transformation.  
(A-C) Different letters indicate statistically significant differences (mixed linear model, adjusted p-
value≤0.05). Error bars represent normalised mean standard error. Data from three independent 
experiments. 
 
Since PIF4 belongs to the same TF class as MYC2 the EDS1 promotion effect might apply 
to bHLH TFs in general. Therefore I decided to test two other classes of TFs, MADS-box 
TFs and MYB TFs. SOC1 (SUPPRESSOR OF OVEREXPRESSION OF CO 1) is a MADS-
box TF, which leads to AP1 expression, while MYB33 (MYB DOMAIN PROTEIN 33) 
increases LFY expression. Both SOC1 and MYB33 were not promoted by EDS1 indicating 
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specificity of EDS1 promoting activity to certain TFs or to bHLH TFs in general (Figure 
2.8B,C). 
2.1.9 MYC2 protein is elevated in eds1-2 plants  
Besides protoplast assays I wanted to quantify EDS1 dependent MYC2 protein levels in 
planta. MYC2 is regulated by the E3-Ubiquitin ligase PUB10 and was shown to accumulate 
after Pst avrRPS4 infection (Jung et al. 2015, Cui et al. 2016). I used transgenic myc2-3 or 
myc2-3/eds1-2 Arabidopsis lines expressing C-terminally 3xflag tagged MYC2 under its 
native promoter (pMYC2:MYC2-flag). 4-week-old plants were either MOCK treated or 
infected with Pst (basal immunity), Pst avrRPS4 (ETI), or Pst avrRPS4 ∆cor (ETI, no 
COR). To bypass COR dependent effects on stomata aperture I infiltrated bacteria into the 
abaxial leaf side with a needleless syringe. Samples were taken at 24 hpi and protein was 
visualised by immunoblot. In pMYC2:MYC2-flag, myc2-3 background MOCK samples 
accumulated low levels of MYC2, which increased after bacterial treatment, even in the Pst 
avrRPS4 ∆cor sample (Figure 2.9A). In pMYC2:MYC2-flag, myc2-3/eds1-2 background 
MYC2 generally accumulated to higher levels even in MOCK samples with highest levels in 
Pst and Pst avrRPS4 samples. Pst avrRPS4 ∆cor did not induce MYC2 (Figure 2.9A). From 
this data the following can be concluded: i) in pMYC2:MYC2-flag, myc2-3, Pst infection 
increases MYC2 protein which seems to be largely COR independent as Pst avrRPS4 ∆cor 
induced MYC2 levels, too, ii) by removing EDS1 basal (MOCK treated) MYC2 increases, 
iii) in pMYC2:MYC2-flag, myc2/eds1-2 MYC2 levels increase after infection mainly 
because of bacterial COR, as Pst and Pst avrRPS4 strongly induced MYC2, while Pst 
avrRPS4 ∆cor did not. 
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Figure 2.9 MYC2 levels depend on pathogen infection and presence of EDS1. 
(A) MYC2-flag protein accumulation in transgenic pMYC2:MYC2-flag myc2-3 or pMYC2:MYC2-
flag myc2-3/eds1-2 plants at 24 hpi with MOCK, Pst, Pst avrRPS4, or Pst avrRPS4 ∆cor. 4-week-
old plants were infiltrated with bacterial solutions (OD600=0.002) and total protein was extracted for 
immunoblot analysis. Note i) overall increased MYC2 protein levels in myc2-3/eds1-2 plants except 
after Pst avrRPS4 ∆cor treatment ii) induced MYC2 after pathogen treatment except in Pst avrRPS4 
∆cor myc2-3/eds1-2. Ponceau-S staining shows equal sample loading.  Repeated four times with 
similar results. 
(B) To the experimental setup from (A) DMSO or 2 µM MG132 was added to the infiltrated 
solution. MYC2-flag protein was visualized via immunoblot with similar results as in (A). Note how 
MG132 treatment decreased MYC2 stability in myc2-3 plants, but increased MYC2 stability in 
myc2-3/eds1-2 plants. Regardless of genetic background MOCK treated MYC2 levels were not 
changed by MG132. Repeated four times with varying results. One representative replicate is shown. 
 
 
After establishing that MYC2 levels in planta at least partially depend on EDS1 I 
hypothesised that EDS1 might steer 26S proteasome activity to modulate MYC2. MYC2 is 
subject to proteasomal turnover and stabilised by MG132 (Shin et al. 2012). To test this I 
performed the same experiment, this time treating each sample with MOCK or 2 µM 
MG132. A total of 4 experiments showed high variation. Figure 2.9B is exemplary for the 
obtained results. Again, in myc2-3 samples Pst infection increased MYC2 levels, but 
surprisingly MG132 lowered MYC2 levels. In myc2-3/eds1-2 plants MG132 treatment led 
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to MYC2 stabilisation as previously reported. Therefore I conclude that in this setup EDS1 
does influence proteasomal regulation of MYC2 although precise conclusions are difficult. 
 
2.1.10 Summary section 2.1 
Data presented in this section establishes a general regulation of MYC2 protein 
accumulation and MYC2 transactivation activity by EDS1/PAD4. Characterisation of the 
used Arabidopsis protoplast system showed that eps protoplasts respond to the bacterial 
effector avrRPS4 when co-expressed with EDS1 and PAD4, but not by mere overexpression 
of EDS1 with PAD4, or by replacing avrRPS4 with the inactive variant avrRPS4KRVY 
(Figure 2.1B). Further, eps cells initiated JA signalling after COR treatment, indicating 
intact signal mechanisms and JA receptive cells (Figure 2.1C). By measuring protein 
accumulation of transiently expressed MYC2 I could show that PAD4 and SAG101, but not 
EDS1 stabilise MYC2 in protoplasts (Figure 2.2A). Native MYC2 transcript was not affected 
by expression of EDS1 family proteins (Figure 2.2B). The fact that EDS1, but not the 
heterodimer deficient version EDS1LLIF dampens the positive PAD4 effect on MYC2 (Figure 
2.2C) indicates that this is a PAD4 specific function that is counteracted by EDS1. As 
MG132 treatment and use of MYC2s showed no qualitative difference in MYC2 
accumulation (Figure 2.3) it is unlikely that the observed differences are linked to 26S 
proteasome or JAZ activity.  
Transactivation assays showed that relatively low levels of MYC2 in EDS1 samples were 
more active, suggesting that the presence of EDS1 is beneficial for MYC2 activity (Figure 
2.4). This is supported by loss of activation of MYC2s (Figure 2.5A,B). This lost promotion 
is not caused by lost interaction between EDS1 and MYC2s although interaction was weaker 
than with MYC2WT (Figure 2.6). Further, the immune status of the cell seems to influence 
EDS1 in its ability to modify MYC2 activity since addition of avrRPS4 abolished MYC2 
promotion (Figure 2.7A,B). The function of avrRPS4 in this context is EDS1/PAD4 
heterodimer independent, because eps protoplasts transformed with EDS1 or PAD4 alone 
showed similar results as protoplasts transformed with EDS1 and PAD4. 
I further show that EDS1 can promote another bHLH TF, PIF4, suggesting that EDS1 might 
act TF class specifically (Figure 2.8A). This is supported by the fact that SOC1 and MYB33, 
a MADS-box and a MYB TF, respectively, were not promoted by EDS1 (Figure 2.8B,C).  
Results 
 
 30 
In planta infection assays using transgenic myc2-3 or myc2-3/eds1-2 lines expressing 
pMYC2:MYC2-flag showed elevated MYC2 accumulation in MOCK treated myc2-3/eds1-2 
plants (Figure 2.9A). This seems contradictory to the promotion on transactivation activity, 
yet as I have shown previously, protein amount and protein activity do not always correlate 
(Figure 2.2, 2.4, 2.5, 2.7). Infection with Pst or Pst avrRPS4 induced MYC2 which was 
stronger in myc2-3/eds1-2 background (Figure 2.9A). Surprisingly, Pst avrRPS4 ∆cor in 
myc2-3 induced MYC2 even stronger, while in myc2-3/eds1-2 the lack of COR was 
mirrored by low MYC2 levels. Adding the proteasome inhibitor MG132 generally had 
opposing effects. It reduced MYC2 accumulation in myc2-3 background, but stabilised 
MYC2 in myc2-3/eds1-2 plants (Figure 2.9B). 
By unravelling a general role of EDS1 family members in MYC2 regulation the question 
arises how this takes place mechanistically and what the biological significance is.  
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2.2 Exploring mechanistic regulation of MYC2 by EDS1 
Section 2.1 established a general regulatory link between EDS1/PAD4 and MYC2. The 
nature of this regulation depends likely on the immune status of the cell (unchallenged, 
basal, ETI), developmental stage, and time. While it is challenging to find the “right” setting 
to observe the specific regulation in the respective context, some basic regulatory features 
can be identified and tested. In this section I address three major ways of MYC2 regulation 
and test whether EDS1/PAD4 alter them. These include MYC2 homodimerisation, JAZ 
repression, and MYC2 post-translational modifications. 
2.2.1 EDS1 does not change MYC2 dimerisation properties 
For correct function MYC2 needs to dimerise and bind DNA. Given the positive effect 
EDS1 had on MYC2 transactivation activity (see Figure 2.4) I hypothesised that EDS1 
might influence MYC2 dimerisation. I tested this by co-expressing SH-MYC2 with MYC2-
flag in Arabidopsis eps protoplasts with YFP, EDS1-YFP, or EDS1-YFP, PAD4-YFP with 
avrRPS4-HA. The latter sample tells whether simulated ETI would affect MYC2 
dimerisation. MYC2-flag co-IPed SH-MYC2 in all samples showing clear 
homodimerisation regardless of presence or absence of EDS1 or ETI signalling (Figure 
2.10). Therefore I conclude that MYC2 dimerisation properties are not affected by EDS1 
and are irrelevant for the observed regulation of MYC2 protein and its activity. 
 
Figure 2.10 EDS1 does not interfere with MYC2 
homodimerisation. 
Co-IP analysis of MYC2-flag with SH-MYC2, with 
or without co-expressed EDS1-YFP, PAD4-YFP, 
avrRPS4-HA or SH-YFP. IP with flag beads 14 h 
after transformation of eps protoplasts. SH-YFP 
served as control. Asterisk indicates low avrRPS4 
expression in input sample. SH: StrepII-3xHA. 
Ponceau-S staining shows equal sample loading. 
Performed twice with similar results. 
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2.2.2 EDS1 does not interact with JAZ9 or JAZ10 
MYC2 activity is restricted by JAZ repressor proteins. Unpublished data from our 
collaborator Alain Goossens (VIB, Ghent, BE) indicated interaction between EDS1 and the 
majority of JAZ proteins, including JAZ9 and JAZ10, in Y2H (yeast-two-hybrid) assays 
(personal communication). To answer whether EDS1 interacts with JAZ proteins in 
Arabidopsis I co-expressed EDS1-flag with JAZ9-YFP or JAZ10-YFP. EDS1 did not IP 
JAZ9 or JAZ10, but strongly co-IPed PAD4 serving as positive control and giving context 
of interaction strength (Figure 2.11). Changing tags, the position of tags (N-terminal vs. C-
terminal), or direction of IP had no effect on this (data not shown). Since I test only two JAZ 
members here, I cannot rule out that EDS1 interacts with other JAZ proteins.  
 
Figure 2.11 EDS1 does not interact with JAZ9 or JAZ10. 
Co-IP analysis of EDS1-flag co-expressed with JAZ9-YFP, JAZ10-YFP, or PAD4-YFP. IP with 
flag-beads 14 h after transformation of eps protoplasts. GUS-flag served as control. EDS1 does not 
co-IP JAZ9 or JAZ10, but strongly binds to PAD4. Ponceau-S staining shows equal sample loading. 
SH: StrepII-3xHA. Performed thrice with similar results. 
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2.2.3 EDS1 does not change MYC2 ubiquitination 
MYC2 is a master TF in JA signalling and has been studied extensively (Kazan et al. 2013). 
This is why numerous post-translational modifications have been discovered. Most well 
understood is the ubiquitin dependent proteasomal turnover by the 26S proteasome. 
Phosphorylation of MYC2T328 is necessary for maintaining MYC2 turnover and 
transactivation activity (Zhai et al. 2013) while the E3 ligase PUB10 polyubiquitinates 
MYC2 (Jung et al. 2015). The observed EDS1 promotion effect on MYC2 might be caused 
by high protein turnover ensuring a pool of active MYC2. To test whether altered MYC2 
ubiquitination levels supported this I co-expressed MYC2-flag with YFP or EDS1-YFP in 
Arabidopsis eps cells. Samples with 10 µM MG132 or with GUS-flag instead of MYC2-flag 
served as controls. I performed flag IP to enrich protein and visualised ubiquitination in 
input and IP samples with a commercially available primary anti-ubiquitin antibody (see 
section 4.1.5 in Materials).  
         
Figure 2.12 EDS1 does not affect MYC2 ubiquitination. 
Immunoblot analysis of MYC2-flag expressed in eps protoplasts with or without EDS1-YFP and 10 
µM MG132. YFP and GUS-flag served as controls. Protein was extracted 15 h after transformation 
and detected by anti-ubiquitin antibody. Note how MG132 treatment increases overall ubiquitination, 
but EDS1 does not change the MYC2 specific ubiquitination pattern. Ponceau-S staining shows 
equal sample loading. Performed thrice with similar results. 
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MG132 stabilised ubiquitination on MYC2, but I did not observe EDS1 dependent changes 
in the ubiquitination pattern (Figure 2.12).  
While it is still possible that EDS1 affects ubiquitination of certain MYC2 residues only, I 
conclude that EDS1 does not change the overall MYC2 ubiquitination profile. 
2.2.4 MYC2 is phosphorylated in an EDS1 dependent manner 
Analysing my immunoblots of MYC2 I observed a weak second band at higher molecular 
weight (see Figure 2.2C, 2.3, 2.6). Given published information (Durek et al. 2010, Zhai et 
al. 2013, Sethi et al. 2014) I hypothesised this to be phosphorylated MYC2. To confirm this 
I co-expressed SH-MYC2 with YFP or PAD4-YFP in eps protoplasts and treated the 
extracted protein with lambda protein phosphatase (λ-PP) or phosphatase inhibitors (P-stop). 
I chose to test MYC2 in presence of PAD4 because PAD4 stabilises MYC2 protein 
simplifying protein detection. Separating the protein via regular SDS-PAGE was sufficient 
to resolve the slight migration changes caused by phosphorylation. Addition of λ-PP 
reduced the second band and caused the overall protein to run at lower molecular weight, 
indicating lost phosphorylation (Figure 2.13A). Addition of P-stop had the opposite effect 
(Figure 2.13A). This shows that MYC2 is phosphorylated in Arabidopsis eps protoplasts and 
that separation via regular SDS-PAGE is sufficient for resolving phosphorylation dependent 
migration patterns. 
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Figure 2.13 MYC2 is phosphorylated in eps protoplasts and transgenic plants. 
(A) MYC2 phosphorylation assay of SH-MYC2 expressed in eps protoplasts for 14 h. Protein was 
separated and visualised by standard immunoblot analysis. PAD4-YFP was co-expressed to increase 
MYC2 accumulation. Note how λ-PP treatment decreases molecular weight. Asterisks indicate 
additional band of phosphorylated MYC2. λ-PP: lambda protein phosphatase; P-stop: phosphatase 
stop.  
(B) MYC2 protein accumulation in transgenic pMYC2:MYC2-flag myc2-3 or pMYC2:MYC2-flag 
myc2-3/eds1-2 plants at 24 hpi with MOCK, Pst, Pst avrRPS4, or Pst avrRPS4 ∆cor. 4-week-old 
plants were infiltrated with bacterial solutions (OD600=0.002) and total protein was extracted, treated 
with or without λ-PP and used for immunoblot analysis. Neither infection, nor genotype (myc2-3 vs. 
myc2-3/eds1-2) affected the observed MYC2 phosphorylation. 
(A,B) Ponceau-S staining shows equal sample loading. Performed thrice with similar results. 
 
 
To connect MYC2 phosphorylation to EDS1 function I extracted MYC2 protein from 
pMYC2:MYC2-flag myc2-3 or myc2-3/eds1-2 plants infiltrated with MOCK, Pst, Pst 
avrRPS4, or Pst avrRPS4 ∆cor (OD600=0.002, 24 hpi). Protein was then split in a λ-PP 
treated and a non-treated fraction. I hypothesised that MYC2 phosphorylation would either 
depend on immune status of the plant, or presence/absence of EDS1. Again, λ-PP treatment 
caused the overall protein to run lower, but this was observed in all treatments (MOCK and 
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infection) and therefore not immunity related (Figure 2.13B). Further this seems to be 
independent of EDS1, as phosphorylation patterns were identical between myc2-3 and myc2-
3/eds1 plants (Figure 2.13B). I therefore conclude that overall MYC2 phosphorylation is 
independent of pathogen infection and/or EDS1.  
2.2.5 Mass spectrometry reveals EDS1 dependent phosphorylation of 
MYC2S123 
Testing global protein phosphorylation via SDS-PAGE is rather crude and modifications on 
single residues are easily missed or cannot be mapped. To investigate the role of EDS1 on 
MYC2 phosphorylation in more detail I designed an IP-nLC-MS/MS experiment. My goal 
was to create an EDS1 dependent in planta phosphorylation profile of MYC2 in pathogen 
challenged and unchallenged conditions. The experimental setup can be seen in Figure 
2.14A. pMYC2:MYC2-flag plants with (myc2-3) or without EDS1 (myc2-3/eds1-2) were 
either MOCK or Pst avrRPS4 (OD600=0.1, 6 hpi) treated followed by protein extraction, 
MYC2-flag IP, purification, digestion, and nLC-MS/MS phospho-analysis. I chose a high 
bacterial load to ensure rapid and strong initiation of ETI and harvested samples 6 hpi in the 
hope to catch early, transient changes of MYC2 status. For feasibility, I focused on 
comparing MOCK and Pst avrRPS4, omitting Pst and Pst avrRPS4 ∆cor. ETI was induced 
in harvested samples as shown by EDS1 and PBS3 induction in pMYC2:MYC2-flag myc2-3 
leaves (Figure 2.14B). Protein digestion, handling of mass spectrometer, and data analysis 
was performed by our MPIPZ core facility. Analysis showed a MYC2 sequence coverage of 
47.2 % consisting of 22 unique peptides. Within the identified peptides, one amino acid was 
phosphorylated in an EDS1 dependent, but infection independent manner. MYC2S123 
(hereinafter S123) was phosphorylated in both MOCK and Pst avrRPS4 treated samples 
lacking EDS1 (for analytical details see section 4.2.3.6 in Methods) but was not 
phosphorylated in presence of EDS1. This suggests that EDS1 either removes, or prevents 
S123 phosphorylation. Upstream of S123 are two more serines, S121 and S122, that were 
also identified to be phosphorylated, although with a lower probability (Figure 2.14C). 
Interestingly, S123 lies in the JID (JAZ interaction domain) of MYC2 and is therefore an 
interesting candidate for EDS1 regulation on MYC2 via JAZ proteins (Figure 2.14D). If 
S123 had a crucial role in mediating the MYC2-JAZ regulation it should be phylogenetically 
conserved. To address this I aligned MYC2 protein sequences ranging from monocot species 
(e.g. Zea mays), to solanaceous species (e.g. Solanum lycopersicum), to Brassicaceae (e.g. 
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Arabidopsis thaliana). S123 was conserved in 5 out of 9 tested species, suggesting an 
important role across many, but not all tested plant species (Figure 2.14E). 
 
 
 
Figure 2.14 MYC2S123 is phosphorylated EDS1 dependently. 
(A) Scheme of IP-nLC-MS/MS experimental setup. 4-week-old transgenic pMYC2:MYC2-flag 
myc2-3 or pMYC2:MYC2-flag myc2-3/eds1-2 plants were infiltrated with MOCK or Pst avrRPS4 
(OD600 = 0.1) and samples were taken 6 hpi. After flag IP and washing, protein extracts were trypsin 
digested and analysed for MYC2 phosphorylation by nLC-MS/MS. Three replicates from the same 
experiment were analysed, showing similar results. 
(B) qRT-PCR analysis of EDS1 and PBS3 showing activation of immune signalling in sampled 
tissue. Statistical analysis with mixed linear model, * = adjusted p-value≤0.01, *** = adjusted p-
value≤0.001. Error bars represent normalised mean standard error.  
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(C) Identified MYC2 peptide with EDS1 dependent phosphorylation pattern. S123 was 
phosphorylated only in absence of EDS1. Pst avrRPS4 treatment did not have an effect. S121 and 
S122 were identified to be phosphorylated, too, but with a lower probability (for detailed cut-offs, 
FDR, and data analysis please see section 4.2.3.6 in Methods). Three replicates from the same 
experiment were analysed, showing similar results. 
(D) Scheme of MYC2 protein domains. S123 lies in the JID. JID: JAZ interaction domain, TAD: 
transactivation domain, bHLH: DNA binding domain. Numbers indicate amino acid position. 
(E) Phylogenetic conversation of AtMYC2S123 (highlighted box) in various species including 
Poaceae (monocots), Solanaceae and Brassicaceae (both dicots). 
 
2.2.6 MYC2S123A/D retain interaction with EDS1 family proteins and 
JAZ9/10 
With S123 lying in the JID and being partly conserved I decided to mutate this serine to 
phospho-mimic aspartate (D) or phospho-dead alanine (A) (Thorsness et al. 1987, Chen et 
al. 2015) and test putative functional implications.  
I generated SH-MYC2S123A and SH-MYC2S123D variants. An approach to mutate S121, 
S122, and S123 altogether did not succeed (for discussion of this see section 3.2.3). First, I 
tested whether MYC2S123A/D retained interaction with EDS1 family proteins in eps 
protoplasts. Both SH-MYC2S123A and SH-MYC2S123D showed similar interaction like SH-
MYC2WT with strong interaction with PAD4-YFP and weak interaction with EDS1-YFP, 
SAG101-YFP or EDS1-flag/PAD4-YFP heterodimer (Figure 2.15, compare to (Cui et al. 
2018)). Thus, changing S123 to alanine or aspartate does not affect MYC2 interaction with 
EDS1 family proteins. 
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Figure 2.15 MYC2S123A and MYC2S123D retain interaction with EDS1 family proteins. 
Co-IP analysis of SH-MYC2S123A or SH-MYC2S123D with EDS1-YFP, PAD4-YFP, SAG101-YFP, or 
PAD4-YFP plus EDS1-flag. Proteins were transiently expressed in eps protoplasts, harvested 14 h 
after transformation, and IPed using GFP-trap beads. YFP served as control. Interaction resembles 
MYC2WT (Cui et al. 2018). SH: StrepII-3xHA. Ponceau-S staining shows equal sample loading. 
Performed twice with similar results. 
 
Given that S123 lies in the JID I decided to test MYC2S123A/D interaction with JAZ proteins. 
As before I tested two JAZ members for MYC2 interaction, JAZ9 and JAZ10. Like SH-
MYC2WT, SH-MYC2S123A and SH-MYC2S123D were co-IPed by JAZ9-YFP and JAZ10-
YFP, respectively (Figure 2.16). Therefore the S123A/D mutation does not affect MYC2 
binding to JAZ9 or JAZ10, but could interfere with interaction of other JAZ proteins. 
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Figure 2.16 MYC2S123A and MYC2S123D retain interaction with JAZ9 and JAZ10. 
Co-IP analysis of SH-MYC2, SH-MYC2S123A, or SH-MYC2S123D with JAZ9-YFP or JAZ10-YFP. 
Proteins were transiently expressed in eps protoplasts, harvested 14 h after transformation, and IPed 
using GFP-trap beads. YFP served as control. Like MYC2WT, MYC2S123A and MYC2S123D interact 
with JAZ9 and JAZ10. SH: StrepII-3xHA. Ponceau-S staining shows equal sample loading. 
Performed twice with similar results. 
 
2.2.7 MYC2S123A/D transactivation activity is changed 
With protein-protein interactions unchanged I investigated whether MYC2S123A/D 
transactivation activity was still enhanced by EDS1. I transformed eps protoplasts with SH-
MYC2WT, SH-MYC2S123A, or SH-MYC2S123D and checked LOX3 and VSP1 transcript. 
MYC2WT replicated the earlier observation of EDS1 promoting MYC2 outputs (Figure 
2.17A,B). The same was true for MYC2S123D (Figure 2.17A,B). Interestingly, EDS1 did not 
promote MYC2S123A activity in the VSP1 branch, but showed MYC2WT like expression in 
the LOX3 branch (Figure 2.17A,B). LOX3 expression levels in YFP plus MYC2WT, 
MYC2S123A, and MYC2S123D were similar, but for VSP1 YFP plus MYC2S123A samples 
showed elevated VSP1 levels even in YFP co-expressed samples (Figure 2.17A,B). This 
suggests a higher basal activity of MYC2S123A and might explain why EDS1 does not 
promote its activity further. This data indicates that LOX3 and VSP1 are differentially 
affected by S123A/D mutation, possibly because of different MYC2 signalling branches. 
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Again, I verified correct protein expression to exclude that the observed effects are caused 
by lack of protein (Figure 2.17C). 
 
Figure 2.17 EDS1 does not promote the VSP1 branch of MYC2S123A. 
MYC2 transactivation activity assay via qRT-PCR. SH-MYC2WT (grey bars), SH-MYC2S123A (blue 
bars), or SH-MYC2S123D (green bars) was expressed with YFP, EDS1-flag, PAD4-YFP, or EDS1-
flag plus PAD4-YFP and LOX3 (A), or VSP1 (B) transcript was measured 14 h after eps protoplast 
transformation. Different letters indicate statistically significant differences (mixed linear model, 
adjusted p-value≤0.05). Error bars represent normalised mean standard error. (C) Immunoblot 
confirming expression of proteins in samples of (A,B). Ponceau-S staining shows equal sample 
loading. SH: StrepII-3xHA. Data from three independent experiments. 
 
2.2.8 The protein kinase EDR1 interacts with MYC2 
The fact that EDS1 prevents S123 phosphorylation suggests the involvement of protein 
kinases or phosphatases. Y2H data from Roger Innes’ group indicated interaction of the 
protein kinase EDR1 (ENHANCED DISEASE RESISTANCE 1) with EDS1 and PAD4 as 
well as with MYC2 (personal communication). I decided to verify these observations in our 
Arabidopsis protoplast system. I used eps protoplasts to co-express YFP-EDR1 and SH-
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MYC2 with or without EDS1-flag/PAD4-flag and with or without avrRPS4-HA. These 
combinations cover basal and immune activated cell states and address whether MYC2-
EDR1 interaction relies on activated immune signalling or not. Regardless of presence of 
EDS1-flag/PAD4-flag or avrRPS4-HA, YFP-EDR1 co-IPed SH-MYC2 (Figure 2.18), 
confirming previous results from the Innes group. Therefore, the MYC2-EDR1 interaction is 
independent of EDS1/PAD4 presence and EDS1/PAD4 heterodimer activity. 
 
     
Figure 2.18 MYC2 interacts with EDR1. 
Co-IP analysis of SH-MYC2 with YFP-EDR1 with or without EDS1-flag, PAD4-flag, and avrRPS4-
HA. SH-PIF4 served as control. Proteins were transiently expressed in eps protoplasts, harvested 14 
h after transformation and IPed using GFP-trap beads. Asterisks indicate MYC2 bands with lower 
molecular weight. Note: the PIF4 negative control seems contaminated here. In two additional, 
independent experiments this was not the case. However, in those replicates I did not observe the 
shifted MYC2 band when co-expressed with EDS1/PAD4. In total this experiment was performed 
thrice and showed consistently binding of EDR1 to MYC2. SH: StrepII-3xHA. Ponceau-S staining 
shows equal sample loading.  
 
2.2.9 EDR1 interacts with PAD4, but not EDS1 
To probe the relationship between MYC2, EDR1, and EDS1/PAD4 further I decided to test 
interaction of YFP-EDR1 with EDS1-YFP and with PAD4-YFP, respectively. Again, I co-
expressed avrRPS4-HA to address putative differences in basal vs. ETI conditions. GFP IP 
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shows that SH-EDR1 is co-IPed by PAD4-YFP in presence or absence of avrRPS4-HA, but 
not by EDS1-YFP (Figure 2.19A). The same is true for reciprocal GFP IP, where YFP-
EDR1 co-IPed PAD4-flag, but not EDS1-flag (Figure 2.19B). However, none of the samples 
contains EDS1 plus PAD4 meaning that avrRPS4 would not trigger EDS1/PAD4 
heterodimer dependent ETI.  
 
Figure 2.19 EDR1 interacts with PAD4, but not with EDS1. 
(A) Co-IP analysis of SH-EDR1 with EDS1-YFP or PAD4-YFP, with or without avrRPS4-HA. 
Proteins were transiently expressed in eps protoplasts, harvested 14 h after transformation, and IPed 
using GFP-trap beads. SH: StrepII-3xHA. Ponceau-S staining shows equal sample loading. 
Performed three times with similar results. 
(B) Reciprocal GFP-IP with EDR1-YFP, EDS1-flag, PAD4-flag, and avrRPS4-HA. 
 
2.2.10 Overall MYC2 phosphorylation is independent of EDS1 or PAD4 
and EDR1 
With EDS1 not interacting with EDR1 a functional connection seems unlikely. However, 
PAD4 might act as a scaffolding protein that brings EDS1 and EDR1 in close proximity that 
could allow functional interaction. Next, I wanted to test the effect of EDS1/PAD4 on 
MYC2 phosphorylation in more detail. For this, I co-expressed SH-MYC2 with YFP-EDR1 
alone, with EDS1-flag, with PAD4-flag, with EDS1-flag/PAD4-flag, with EDS1LLIF-flag, or 
with EDS1LLIF-flag/PAD4-flag. SH-SOC1 served as control. After GFP IP, samples were 
split in two fractions, treated with λ-PP or MOCK, and separated via SDS-PAGE. MYC2 
co-IPed in all samples with EDR1. λ-PP treatment decreased MYC2 molecular weight as 
seen previously (Figure 2.20A), but this was independent of any EDS1-PAD4 combination. 
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In conclusion, EDS1 and PAD4 do not alter overall MYC2 phosphorylation in an EDR1 
dependent manner in Arabidopsis protoplasts. Remarkably, here EDR1 did not interact with 
EDS1 or PAD4, which suggests MYC2 out-competing EDS1 and PAD4 for EDR1 binding. 
 
    
Figure 2.20 Overall MYC2 phosphorylation does not depend on EDR1 or EDS1 family 
proteins. 
(A) Co-IP analysis of SH-MYC2 and YFP-EDR1 with or without EDS1-flag, PAD4-flag, or 
EDS1LLIF-flag. SH-SOC1 served as control. Proteins were transiently expressed in eps protoplasts, 
harvested 14 h after transformation and IPed using GFP-trap beads. Beads were treated with λ-PP 
which resulted in lower MYC2 molecular weight. Co-expressing EDS1-family proteins did not affect 
this. SH: StrepII-3xHA. Ponceau-S staining shows equal sample loading. Performed three times with 
similar results.  
(B) Identical experiment as 2.13A, but in edr1 protoplasts. MYC2 phosphorylation in edr1 and eps 
protoplasts is identical. Performed twice with similar results. 
 
Figure 2.13A shows clear phosphorylation of MYC2 when expressed in eps protoplasts. If 
this phosphorylation was EDR1 dependent it should be lost in edr1 protoplasts. Therefore I 
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repeated the experiment shown in Figure 2.13A using edr1 protoplasts and tested SH-MYC2 
phosphorylation in presence of YFP or PAD4-YFP and treated with λ-PP or P-stop. MYC2 
phosphorylation was not affected by the edr1 mutation indicating that the overall changes of 
MYC2 phosphorylation seen on SDS gels are not EDR1 dependent (Figure 2.20B). 
Consequently, it is unlikely that EDS1 (and PAD4) regulate MYC2 phosphorylation via 
EDR1. While this holds true for overall MYC2 phosphorylation, it is still possible that 
EDR1 acts on specific MYC2 residues only and that this is regulated by EDS1.  
 
2.2.11 Phospho-regulatory proteins are mis-expressed in eds1-2 
plants 
EDR1 was an interesting candidate to test as it is a protein kinase reported to be a negative 
regulator of immunity that interacts with MYC2 and PAD4. However, EDS1 might target 
any other kinase, phosphatase or immunity-related gene that would lead to altered MYC2 
phosphorylation. For further insights I made use of an available RNA-seq (RNA-
sequencing) dataset described by our group earlier (Bhandari et al. 2019). I analysed RNA-
seq data from Arabidopsis WT and eds1-2 plants focussing on genes linked to 
phosphorylation or immunity. For statistical analysis a cut-off of |log2 FC| ≥1, and a 
FDR≤0.05 was used. Transcript of genes of interest like MYC2, EDR1, FER (FERONIA, see 
section 3.2.6 in discussion), MKK6, MPK3/6, BIK1, CNI1 was unchanged. Genes repressed 
by EDS1 (transcript up in eds1-2) include MAPKKK13, 15, 17, GSO1, JAZ9, and JAZ10 
although the latter two were not statistically significantly changed. Genes promoted by 
EDS1 (transcript down in eds1-2) include MKK4, MPK11, SERK4, WAK3, CRK7, CRK36, 
PBS3 and PYL6 (Figure 2.21).  
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Figure 2.21 Numerous phosphorylation-related proteins are mis-regulated in eds1-2 plants. 
RNA-seq data analysis of WT (Col-0) and eds1-2 plants showing genes related to immunity and/or 
protein phosphorylation. Asterisks indicate genes passing filtering with a |log2 FC| ≥1, FDR≤0.05 
cut-off. 
 
While this list by no means is exhaustive, it does show that the transcript of numerous genes 
that are linked to protein phosphorylation or immunity is regulated by EDS1 and provides 
potential new candidates for further studies. 
 
2.2.12 Summary section 2.2 
The EDS1 dependent regulation of MYC2 transactivation activity shown in section 2.1 
could be explained by various mechanisms. In this section I have demonstrated that EDS1 
regulates MYC2 most likely via MYC2 phosphorylation, but not via MYC2 dimerisation 
(Figure 2.10) or MYC2 ubiquitination (Figure 2.12). To what extent JAZ proteins and 26S 
proteasome are involved needs further investigation. 
MYC2 is known to be phosphorylated in planta (Heazlewood et al. 2008, Zhai et al. 2013, 
Sethi et al. 2014) and I observed phosphorylation of transiently expressed MYC2 in 
Arabidopsis protoplasts (Figure 2.13A, 2.20) as well as in plants treated with MOCK or Pst 
(Figure 2.13B). Mass spectrometry identified MYC2S123 to be phosphorylated in an EDS1 
dependent manner, indicating direct or indirect regulation of S123 phosphorylation status by 
Results 
 
 47 
EDS1 (Figure 2.14). This is of interest since S123 is positioned in the JID of MYC2 and is 
partly conserved (Figure 2.14). Mutation of S123 to phospho-mimic aspartate (D) or 
phospho-dead alanine (A) did not affect MYC2 interaction with EDS1 or PAD4 (Figure 
2.15), or with JAZ9 or JAZ10 (Figure 2.16).  
Testing the ability of EDS1 to promote MYC2S123A/D transactivation activity, I found that 
MYC2S123A/D was behaving like MYC2WT when testing LOX3 levels (Figure 2.17A). 
Regarding VSP1, EDS1 enhanced MYC2S123D transactivation activity, but not MYC2S123A 
transactivation activity (Figure 2.17B). This suggests phospho-dependent, EDS1-dependent 
MYC2 regulation via S123 that might differ between distinct MYC2 signalling branches.  
S123 being phosphorylated in the absence of EDS1 could be explained by EDS1 inhibiting a 
kinase or promoting a phosphatase. I demonstrate that PAD4, but not EDS1 binds the 
protein kinase EDR1 (Figure 2.19) and that EDR1 does bind MYC2 (Figure 2.18). These 
interactions are independent of avrRPS4, i.e. independent of the cell’s immune status. 
However, I could not connect overall MYC2 phosphorylation to be regulated by EDR1. 
Also, my data do not suggest EDS1 (or PAD4) regulating EDR1 kinase activity (Figure 
2.20A). The fact that overall MYC2 phosphorylation is unchanged in eps and edr1 
protoplasts (compare Figure2.13A and 2.20B) suggests that EDR1 does not affect the 
MYC2 phosphorylation pattern, but it is still feasible that EDS1 regulates EDR1 in order to 
control single residues like S123. 
Comparing WT and eds1-2 RNA-seq data allows to screen for genes of interest like kinases, 
phosphatases, or genes related to the 26S proteasome machinery or in general plant 
immunity in order to provide new potential candidates to test. Interesting candidates include 
FER, MKK4/11, MPK3/6, MAPKKK13/15/17, CDPK1, SERK4, WAK3, PYL6 and others 
(Figure 2.21). 
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3 Discussion 
EDS1 and its interaction partners PAD4 and SAG101 are crucial proteins in plant immunity. 
Roles for EDS1 have been described in basal and TNL triggered immunity (Falk et al. 1999, 
Feys et al. 2001, Wiermer et al. 2005, Rietz et al. 2011). In context of TNL signalling EDS1 
functions as a decision-making node, triggering SA dependent and independent pathways 
(Wiermer et al. 2005, Venugopal et al. 2009, Cui et al. 2016). While eds1 or pad4/sag101 
plants are unable to transduce TNL signalling, many (but not all) CNLs act EDS1 
independently (Wiermer et al. 2005, Xiao et al. 2005, Day et al. 2006, Bhandari et al. 2019). 
Why this is and if EDS1/PAD4 phylogenetic conservation across seed plants is important 
remains elusive. EDS1 interacts with various TNLs such as RPS4, RPS6, and SNC1 
(Bhattacharjee et al. 2011), VICTR (Kim et al. 2012) and the effector protein avrRPS4 
(Bhattacharjee et al. 2011, Huh et al. 2017) suggesting that EDS1 serves as a junction for 
further immune signalling. With its central role the EDS1/PAD4 node represents a 
worthwhile target for effectors in order to overcome plant immunity. Despite its importance, 
our understanding of EDS1 molecular function remains scarce. 
Recently, our group employed a forward genetic screen in Arabidopsis to find components 
that are repressed by TNL-activated EDS1. To this end, EMS (ethane-methyl sulfonate)-
mutagenised eds1-2 plants were infected with Pst avrRPS4 and screened for restored 
resistance. From ~650000 M2 plants, 12 independent mutations in COI1 were found. COI1 
encodes a F-box protein that binds active JA-Ile or COR and initiates JA signalling (Sheard 
et al. 2010). Further analysis showed that COI1 is required for COR dependent virulence of 
Pst avrRPS4 and that TNL-activated EDS1 represses JA signalling. Bacterial growth was 
similar in eds1-2/myc2-3, and eds1-2/coi1-41 plants, being intermediate between WT and 
eds1-2. This indicates that EDS1 represses COR induced bacterial virulence mainly by 
repressing the MYC2 branch of JA signalling. These experiments reveal a new intersection 
between ETI and JA signalling with ETI-activated EDS1 repressing MYC2 activity (Cui et 
al. 2018). 
With MYC2 being a promising candidate to gain insights about the molecular function of 
EDS1, I decided to interrogate the relationship between EDS1 and MYC2 further. My aim 
for this thesis was to i) probe the effect of EDS1 family proteins on MYC2 accumulation 
and activity in non-triggered conditions, and to ii) find a mechanistic basis for EDS1 
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regulation of MYC2 activity. In the following section I will summarise my results, discuss 
their functional implications and their shortcomings, and put them in context of current 
literature. In the last paragraph I will discuss future experiments. 
 
3.1 Impact of EDS1 family proteins on MYC2 abundance and 
transactivation activity 
EDS1 represses the MYC2 branch of JA signalling during Pst avrRPS4 infection, but not in 
non-infected conditions (Cui et al. 2018). However, all EDS1 family members interact with 
MYC2 in basal, i.e. non-infected conditions (Cui et al. 2018). While it is reasonable that an 
external trigger like avrRPS4 initiates EDS1 repression on MYC2, two observations are 
striking. First, the aforementioned interaction of EDS1, PAD4, and SAG101 with MYC2 in 
basal conditions and second, the difference in protein accumulation and the seemingly 
different interaction strength with strong interaction between MYC2 and PAD4 or SAG101 
and weak interaction with EDS1 (Cui et al. 2018). If EDS1-MYC2 interaction is necessary 
and sufficient for EDS1 repression of MYC2 signalling remains unknown. 
3.1.1 PAD4 and SAG101 stabilise MYC2 protein levels 
To get a basic understanding of the EDS1-MYC2 relationship I co-expressed MYC2 with 
each one of the EDS1 family proteins in Arabidopsis eps protoplasts. Interestingly, MYC2 
protein was stabilised by PAD4 and SAG101, but not by EDS1 (Figure 2.2A). This cannot 
be explained by elevated MYC2 transcript levels, as native MYC2 transcript was not affected 
by expression of EDS1 family proteins (Figure 2.2B). Further tests showed that formation of 
the EDS1/PAD4 heterodimer abolishes the PAD4 stabilising effect on MYC2 (Figure 2.2C). 
This data indicates that PAD4 (and SAG101) regulate MYC2 post-translationally. This was 
not changed by addition of avrRPS4, which induces ETI-like signalling when co-expressed 
with EDS1 and PAD4 (Figure 2.1B), and is therefore independent of the cells immune status 
in this transient assay (Figure 2.2C). Higher MYC2 accumulation in presence of PAD4 
would explain the apparent stronger interaction observed by Cui et al. (2018). Noteworthy, 
PAD4 or SAG101 did not bind MYC2 in Y2H assays, indicating indirect interaction of these 
proteins (Cui et al. 2018). An interesting aspect is that EDS1, PAD4, and SAG101 interact 
with MYC2 in their monomeric, i.e. non-EDS1/PAD4 or EDS1-SAG101 heterodimer form 
(Cui et al. 2018) and here I show monomer specific effects on MYC2 protein accumulation 
(Figure 2.2A) and MYC2 transactivation activity (Figure 2.4, 2.5). So far, we know very 
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little about the function of EDS1 family proteins as monomers. Overexpression of either 
EDS1 or PAD4 does not lead to autoimmunity or defence priming, while constitutive 
expression of EDS1 with PAD4 does cause autoimmunity (Cui et al. 2016). For PAD4, 
numerous studies reported an EDS1 independent function in resistance signalling against 
green peach aphid (GPA). Detailed analysis showed that PAD4 is necessary and sufficient 
for proper resistance to GPA (Pegadaraju et al. 2005, Pegadaraju et al. 2007, Louis et al. 
2012). Recent work in our group further showed that PAD4LLD, an EDS1 non-interacting 
mutant, is fully functional in GPA resistance signalling, while being defective in ETI 
signalling (Dongus, J., personal communication). Thus, PAD4 acts distinctly different in 
resistance to GPA compared to ETI. EDS1 and PAD4 are best characterised in the context 
of ETI, where they act as a heterodimer and heterodimerisation-deficient mutants like 
EDS1LLIF are non-functional during ETI (Feys et al. 2001, Wagner et al. 2013). Further, 
PAD4 did not stabilise MYC2 in presence of EDS1 (Figure 2.2C), indicating different 
functions of PAD4 and EDS1/PAD4 in context of MYC2 protein accumulation. 
3.1.2 PAD4 specific MYC2 stabilisation is independent of proteasomal 
activity and JAZ repression 
PAD4 could stabilise MYC2 by different means. Among other things, it could protect 
MYC2 from protein turnover by the 26S proteasome, or by releasing it from JAZ 
suppression. Proteasomal turnover of MYC2 had been observed before (Shin et al. 2012, 
Zhai et al. 2013) and had been confirmed by Jung et al. (2015) showing PUB10 dependent 
polyubiquitination and subsequent degradation of MYC2. Since neither MG132 treatment, 
nor use of the JAZ repressor uncoupled MYC2 variant MYC2s (Goossens et al. 2015) 
showed qualitative difference in MYC2 stabilisation by PAD4 (Figure 2.3), I concluded that 
the observed differences in MYC2 accumulation have another cause. 
3.1.3 EDS1 promotes MYC2 transactivation activity  
While protein accumulation can be informative about a protein’s function, protein amount 
and protein activity are not necessarily correlated (Lipford et al. 2005, Collins et al. 2006, 
Spoel et al. 2009). To understand the functional relevance of stabilised MYC2 by PAD4, I 
employed a qRT-PCR based transactivation activity assay. To my surprise, this assay 
showed that MYC2 activity, measured by relative expression of MYC2 target genes LOX3, 
VSP1, and ORA59, was promoted by EDS1, but not by PAD4, or by EDS1 with PAD4 
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(Figure 2.4A-C). This is in clear contrast to the observed MYC2 protein accumulation 
pattern in which PAD4, but not EDS1 promoted MYC2 accumulation (Figure 2.2A,C, 
2.4D). Notably, MYC2 repression of ORA59 was promoted by EDS1, PAD4, and EDS1 
with PAD4 making the ORA59 results more difficult to interpret. Nevertheless, the observed 
trend holds true for promotion of MYC2 transcriptional activation and repression functions. 
MYC2 is a TF and has been shown to rely on an “activation by destruction” mechanism 
(Zhai et al. 2013). In their work the authors hypothesise that constant destruction and 
subsequent de novo synthesis of MYC2 ensures a primed, “ready-to-act” protein pool. This 
could explain the discrepancy between high MYC2 protein accumulation and low MYC2 
activity in presence of PAD4 and low MYC2 protein abundance, but high MYC2 activity in 
presence of EDS1. In this scenario, the accumulated MYC2 in PAD4 samples represents an 
inactive pool of MYC2, which either cannot be activated or has been activated earlier. The 
“activation by destruction” relies on phosphorylation of MYC2T328 (Zhai et al. 2013) and I 
will discuss MYC2 phosphorylation more detailed in section 3.2.3. 
3.1.4 MYC2s is not promoted by EDS1 but retains interaction with EDS1 
family proteins 
To find the mechanism behind MYC2 regulation by EDS1 I made use of the JAZ uncoupled 
MYC2s (MYC2D105N, Goossens et al. 2015). My reasoning was that EDS1 might promote 
MYC2 activity by releasing it from JAZ suppression. If true, MYC2s should not be 
promoted by EDS1. Indeed, LOX3 and VSP1 levels were unchanged in MYC2s samples, but 
promoted by EDS1 in MYC2WT samples (Figure 2.5A,B). This was not caused by low 
protein expression (Figure 2.5C), or lost interaction of EDS1 with MYC2s (Figure 2.6). 
However, interaction with MYC2s was considerably weaker than with MYC2WT, suggesting 
that the JID, and specifically MYC2D105 is important for EDS1 protein family interaction 
with MYC2. It is conceivable that EDS1 and JAZ proteins share a common structural motif 
via which they competitively bind MYC2. Preliminary tests by my colleague Deepak 
Bhandari do not support this, but more detailed analysis will be needed to answer this 
definitely (Bhandari, D., personal communication). 
Taken together, EDS1 is likely to steer MYC2 activity by interfering with MYC2-JAZ 
regulation. Another experiment to address this in more detail in planta relies on myc2-3 or 
eds1-2/myc2-3 transgenic lines expressing 35S:SH-MYC2WT or 35S:SH-MYC2s. These lines 
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are being selected and results will hopefully be obtained in summer 2019. Please refer to 
Perspectives (section 3.4) for further notes on this. 
When co-expressed with PAD4, EDS1 lost its promoting activity, resembling my previous 
observations that these results are specific to the monomeric protein and not to EDS1/PAD4 
heterodimers. 
3.1.5 Expression of avrRPS4 abolishes EDS1 promotion of MYC2 
Since Cui et al. (2018) showed EDS1 repressing MYC2 in TNL-triggered immunity 
conditions my opposing observation of EDS1 promoting MYC2 transactivation activity 
(Figure 2.4) was puzzling. However, a major difference of the two analyses is the immune 
context of the experiment. EDS1 repressed MYC2 only in Pst avrRPS4 infected tissues. In 
my assays cells are non-infected. Therefore I examined whether promotion of MYC2 by 
EDS1 would be affected by addition of the bacterial virulence factor avrRPS4. Co-
expression of avrRPS4 with MYC2 and EDS1 indeed abolished EDS1 dependent MYC2 
promotion (Figure 2.7). This shows that EDS1 regulates MYC2 differently depending on the 
immunity context and subsequently on the status of EDS1. An alternative explanation is that 
in presence of avrRPS4, EDS1 focuses on its heterodimer function with PAD4 and is 
therefore not available to promote MYC2. However, in this assay I use eps protoplasts, 
which means that transiently expressed EDS1 cannot heterodimerise with native PAD4 or 
SAG101. The observed differences in avrRPS4 expressing samples can therefore not be due 
to EDS1/PAD4 dependent ETI signalling, but are likely to account for an EDS1/PAD4 
independent activity of avrRPS4. In terms of EDS1 independent functions little to nothing is 
known about avrRPS4. Full virulence function relies on proteolytic processing of the 
effector within the plant cell where both N- and C-terminal peptides contribute to virulence. 
Further, the N-terminal KRVY motif is essential (Sohn et al. 2009, Halane et al. 2018). 
AvrRPS4 interacts with WRKY TFs and likely targets them to promote bacterial virulence 
(Sarris et al. 2015), yet no biochemical activity has been found so far.  
Notably, LOX3 and VSP1 showed different expression patterns in transactivation assays. 
While the EDS1 promoting effect holds true for both genes, VSP1 was elevated in MYC2s 
samples, consistent with a JAZ uncoupled MYC2, while LOX3 was not (Figure 2.5A,B). 
Similarly, in presence of avrRPS4 VSP1 was hardly induced by MYC2, but LOX3 was 
strongly increased, although not promoted by EDS1 (Figure 2.7A,B). This suggests that 
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MYC2 outputs vary between different targets and provides a possibility for EDS1 specific 
regulation of certain, but not all MYC2 outputs. 
Overall, these results suggest an EDS1 specific promotion of MYC2 transactivation activity 
that is related to JAZ proteins and affected by avrRPS4. 
3.1.6 EDS1 specifically promotes bHLH TFs 
EDS1 promoting MYC2 transactivation activity might be a generic feature of EDS1 and not 
limited to MYC2. To address EDS1 promotion specificity I tested if EDS1 affects PIF4 
transactivation activity. PIF4 has been found to balance temperature sensitive plant growth 
and defence by repressing the plant immune system (Gangappa et al. 2016). Still, it was 
unexpected to find EDS1 promoting PIF4 (Figure 2.8A) as no direct functional connection 
between these two proteins had been reported. However, PIF4 and MYC2 are both class IIIe 
bHLH TFs suggesting a more general function of EDS1. This could mean that i) EDS1 is 
not promoting MYC2 by releasing it from JAZ suppression, ii) that EDS1 has different ways 
of promoting different bHLH TFs, or iii) that MYC2 and PIF4 are regulated by the same 
components. MYC2 and PIF4 belong to the type IIIe class of DNA binding bHLH TFs and 
dimerise in order to bind to DNA and initiate transcriptional reprogramming (Toledo-Ortiz 
et al. 2003, Kazan et al. 2013, Goossens et al. 2016). Our group could show via FRET-FLIM 
experiments that EDS1 associates with DNA, likely on chromatin level (Lapin, D., 
Bhandari, D., personal communication). Therefore it is feasible that EDS1 might regulate 
DNA associated TFs when encountering them at the DNA, or in general, making the 
chromatin more accessible for DNA-binding TFs. This is in line with data showing that 
EDS1 does not promote SOC1 and MYB33, both non-bHLH TFs (Figure 2.8B,C). In this 
context it would be interesting to test EDS1 dependent DNA methylation as DNA 
methylation and TF binding can be linked (Zhu et al. 2016). Another, maybe more likely 
explanation of EDS1 promotion of PIF4 is JAZ related. There is no evidence for direct 
regulation of PIF4 by JAZ proteins. However, analogous to MYC2 repression by JAZs, 
PIF4 is repressed by DELLA proteins, the key repressors of GA signalling (Sun 2011). Hou 
et al. (2010) have shown that DELLA proteins interact with JAZ1. This interaction 
sequesters JAZ1 away from MYC2, thereby activating MYC2 target genes like LOX2. With 
this interesting observation of JA pathway regulation by GA signalling components it seems 
possible that this regulation works vice versa, too. Hypothetically, by interacting with 
DELLA proteins, JAZ proteins could repress DELLAs and promote GA signalling. In della 
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quadruple or pif4 mutants, JA inhibition of hypocotyl growth was significantly attenuated, 
suggesting that JA steers photomorphogenesis via DELLAs and/or PIF4 (de Lucas et al. 
2008, Hou et al. 2010). It is tempting to speculate that JAZ proteins indeed release PIF4 
from DELLA suppression. Assuming that EDS1 binds JAZs this would explain how EDS1 
could promote both MYC2 and PIF4 transactivation activities. Further, this is in line with 
the notion that MYC2s cannot be promoted by EDS1 because it is already uncoupled from 
JAZ suppression (Figure 2.5). A caveat of this model is that I could not detect interaction of 
EDS1 with two tested JAZ proteins, JAZ9 and JAZ10 (Figure 2.11). With these promising 
results it will be worth testing the remaining 11 JAZs (JAZ1-8, JAZ11-13) for interaction 
with EDS1 to identify the relevant ones.  
My results further show that the mere over-expression of EDS1 with a TF does not lead to 
enhanced TF activity. The functional relevance of this observation is still to be tested. If 
EDS1 indeed promotes MYC2 activity in a biological meaningful manner this could be a 
means to fine-tune SA-JA crosstalk in basal and ETI conditions. My colleague Jingde Qiu 
showed that MYC2 inhibits EDS1 expression by binding to the EDS1 promoter. With this 
mutual regulation enhanced MYC2 activity might be a self-regulatory loop by which EDS1 
regulates itself (Qiu et al., in prep.).  
3.1.7 MYC2 accumulates in eds1-2 plants 
While transient expression in Arabidopsis protoplasts has its benefits, in planta experiments 
are necessary to address functional implications of the observed results. Comparing MYC2 
protein accumulation in a stable transgenic lines expressing pMYC2:MYC2-flag in myc2-3 or 
myc2-3/eds1-2 background revealed elevated MYC2 levels in i) EDS1 lacking lines (myc2-
3/eds1-2), ii) all infected myc2-3 lines, and iii) Pst and Pst avrRPS4 infected myc2-3/eds1-2 
lines (Figure 2.9A). Elevated MYC2 levels in basal, i.e. MOCK treated myc2-3/eds1-2 lines 
indicate a negative role of EDS1 on MYC2 accumulation even in basal conditions. This 
effect is consistent in Pst and Pst avrRPS4 infected myc2-3/eds1-2 lines, but not in Pst 
avrRPS4 ∆cor infected tissue. One explanation for the high MYC2 levels in Pst and Pst 
avrRPS4 and the low MYC2 levels in Pst avrRPS4 ∆cor infected myc2-3/eds1-2 lines is 
pathogen growth. In eds1-2 plants, growth of avirulent bacteria is ~100-1000 fold higher 
than in WT plants (Feys et al. 2005). Numbers of bacteria producing COR is therefore 
higher, leading to higher MYC2 accumulation. Consequently, COR lacking Pst avrRPS4 
∆cor does not induce MYC2 accumulation. The limitation of this model is that i) MYC2 
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was also enriched in MOCK treated samples, and ii) MYC2 is enriched in Pst avrRPS4 ∆cor 
treated myc2-3 background. Similar to data shown in Figure 2.2A and 2.4, high protein in 
MOCK treated myc2-3/eds1-2 plants could be inactive, while low protein in myc2-3 could 
represent an active protein pool. Therefore I propose a model in which MYC2 accumulation 
depends on EDS1 (basal and TNL-activated), bacterial growth, and COR. Which of these 
components is relevant for MYC2 functional outputs in specific conditions remains to be 
tested in more detail.  
MYC2 accumulation at least partially depends on the 26S proteasome as MG132 treatment 
stabilised MYC2 levels in all myc2-3/eds1-2 lines infected with Pst, but not in MOCK 
treated myc2-3 lines (Figure 2.9B). This is consistent with published results where MYC2 
protein level was elevated in eds1-2 plants (Shin et al. 2012). Strikingly, I observed the 
opposite for myc2-3 lines, suggesting EDS1 dependent regulation of MYC2 by the 26S 
proteasome. Possibly, EDS1-MYC2 regulation on protein level is in a fine-tuned balance, 
which is revealed in absence of COR, but overshadowed by COR during bacterial infection. 
Further complexity is added by the fact that MYC2 is regulated by the circadian clock (Shin 
et al. 2012). To avoid daytime dependent effects on my experiments, all samples were taken 
at 10 a.m.  
The new dimension in my presented data is that monomeric EDS1 and PAD4 influence 
MYC2 in basal, i.e. non-challenged conditions as seen by elevated MYC2 protein levels in 
presence of PAD4, increased transactivation activity in presence of EDS1, and higher basal 
protein accumulation in MOCK treated pMYC2:MYC2-flag myc2-3/eds1-2 plants (Figure 
2.2, 2.4, 2.9). 
The impact of these results ultimately relies on whether one can show function implications 
for EDS1/PAD4 regulation of MYC2 protein accumulation and transactivation activity. In 
planta experiments are necessary to address this in full scope and to elucidate the 
physiological relevance in context of basal and pathogen challenged conditions. 
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3.2 Exploring mechanistic regulation of MYC2 by EDS1 
Together with data from Cui et al. (2018) the previously discussed results establish a 
functional connection between the ETI signalling node EDS1 and the JA master TF MYC2. 
In section 2.2 I addressed possible mechanisms by which EDS1 might regulate MYC2. 
Specifically, I tested MYC2 dimerisation properties, regulation by JAZ proteins, and the 
post-translational modification phosphorylation. 
3.2.1 MYC2 dimerisation is not affected by EDS1 
As discussed section 3.1.6, MYC2 is a bHLH TF that needs to dimerise and to bind to DNA 
for proper function. (Activated) EDS1 did not affect MYC2 dimerisation in transient assays 
(Figure 2.10), making it unlikely that EDS1 would steer MYC2 activity by regulating 
MYC2 DNA binding. Yet this experiment is rather crude and two alternatives remain. First, 
EDS1 could impact MYC2 dimerisation in a more subtle manner which cannot be resolved 
by immunoblot analysis. This could be addressed by using 
microscale thermophoresis (MST), a method that allows high-resolution quantification of 
protein-protein, or protein-nucleic acid interaction. It would be interesting to test if and how 
MYC2 homodimerisation and/or DNA binding changes in presence or absence of EDS1. 
Second, EDS1 might change MYC2 localisation, thereby interfering with its nuclear TF 
activity. However, we have not observed this (multiple group members, unpublished). EDS1 
shuttles between nucleus and cytoplasm with distinct, compartment specific immunity 
outputs (Garcia et al. 2010, Heidrich et al. 2011). It is therefore possible that localisation of 
EDS1 determines its impact on MYC2. TNL-activated, nuclear EDS1 might repress MYC2 
signalling (Cui et al. 2018), while this might differ for non-activated nuclear or cytoplasmic 
EDS1. However, I have not tested this. 
3.2.2 EDS1 does not interact with JAZ9 or JAZ10 
Unpublished Y2H data from Alain Goossens’ group suggested interaction between EDS1 
and the majority of JAZ proteins (personal communication). This would be in line with the 
idea of EDS1 competing with JAZ proteins for MYC2 binding, thereby releasing MYC2 
from JAZ suppression. However, I could not show interaction of EDS1 with JAZ9 or JAZ10 
(Figure 2.11), suggesting that either other JAZ proteins are of importance or that EDS1 
indirectly affects JAZ function. JAZ9 and JAZ10 were promising candidates, as JAZ9 
participates in COI1 dependent JA signalling during stomatal plant immunity (Lee et al. 
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2018) and JAZ10 confers enhanced resistance to Pst infection (de Torres Zabala et al. 2016). 
Further, both JAZ9 and JAZ10 were induced upon Pst infection in a COR dependent, but 
MYC2 independent manner (Demianski et al. 2012). 
With lost promotion of MYC2s by EDS1 in transient assays it is clear that EDS1 does 
regulate MYC2 via JAZ proteins, but the precise mechanism remains unknown. It is 
unlikely that EDS1 needs to be activated or relies on additional components to interact with 
JAZs, because EDS1 did interact with JAZ proteins in Y2H assays (A. Goossens, personal 
communication). Alternatively, EDS1 might interact with COI1 and guide it to close 
proximity with MYC2. This would represent a more upstream control of JA signalling by 
EDS1 and could be tested easily (see Figure 3.1). 
Even if EDS1-JAZ interaction were observed it would be difficult to show functional 
relevance. Therefore I designed an experiment to answer to what extent JAZ proteins are 
relevant for MYC2-EDS1 regulation. Transgenic Arabidopsis lines are being generated and 
first results are expected in June 2019. In this setup C-terminally 3xflag tagged MYC2 
driven by its own promoter (pMYC2:MYC2-flag) is expressed in a myc2-3 or a myc2-3/eds1-
2 genetic background and compared to the JAZ uncoupled MYC2s in the same genetic 
backgrounds (pMYC2:MYC2s-flag). Testing transcript, protein, and target gene expression 
before and after Pst avrRPS4 infection will tell whether EDS1 is affecting the MYC2-JAZ 
regulation and if this has a role in EDS1 immune signalling. 
3.2.3 MYC2S123 is phosphorylated in an EDS1 dependent manner 
Another possibility for MYC2 regulation is via post-translational modifications (PTMs). 
Even though MYC2 has been characterised extensively, information on PTMs is scarce. The 
most well understood MYC2 PTM is phosphorylation. The PhosPhAt database counts 
approximately 10 MYC2 phosphorylation sites (Heazlewood et al. 2008) and functional 
relevance for certain residues has been shown. For instance, MPK6 phosphorylates 
MYC2S123 in blue light conditions during seedling development (Sethi et al. 2014). Zhai et 
al. (2013) connected phosphorylation coupled proteasomal turnover to MYC2T328 in 
promoting JA responses. In their proposed model, MYC2 proteolysis is part of an 
“activation by destruction” regulatory loop that ensures a pool of “ready-to-act” protein. 
Phosphorylation often precedes ubiquitination and subsequent activation of the 26S 
proteasome (Geng et al. 2012). Consequently, two studies show regulation of MYC2 via 
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ubiquitination by the U-box protein PUB10 (Jung et al. 2015), and deubiquitination by the 
ubiquitin proteases UBP12 and UBP13 (Jeong et al. 2017). MYC2 was destabilised by 
overexpression of PUB10 and stabilised in pub10, or PUB10C249A mutants, indicating 
ubiquitin dependent proteolysis of MYC2. Deubiquitination of MYC2 by UBP12 and 
UBP13 prolongs MYC2 half-life and acts antagonistically to PUB10. Direct evidence for 
phosphorylation dependent MYC2 ubiquitination is still elusive, though. When testing 
MYC2 ubiquitination in a transient assay, I did not observe EDS1 dependent changes in the 
MYC2 ubiquitination pattern (Figure 2.12). 
Regarding phosphorylation, I was able to resolve MYC2 phosphorylation via SDS-PAGE 
and show that transiently overexpressed MYC2 is phosphorylated and that MYC2 from 
stable transgenic plants is phosphorylated independently of EDS1 or infection (Figure 2.13). 
An IP-nLC-MS/MS experiment to identify residue specific MYC2 phosphorylation showed 
EDS1 dependent, but infection independent phosphorylation of MYC2S123 (Figure 2.14). 
Since published literature (Heazlewood et al. 2008, Zhai et al. 2013, Sethi et al. 2014) and 
previous test runs had identified multiple phosphorylation sites of MYC2 it is surprising that 
here I identified one phosphorylated residue only. This residue was phosphorylated in 0/6 
replicates (pMYC2:MYC2-flag, myc2-3), and in 5/6 replicates (pMYC2:MYC2-flag, myc2-
3/eds1-2). S123 is the last in a row of three serines and one could claim that if S123 is 
mutated, S121 or S122 might compensate for a non-functional S123. Two instances argue 
against this. First, Sethi et al. demonstrated that MPK6 phosphorylates MYC2 specifically at 
S123 (Sethi et al. 2014) and second, S123, but not S121 or S122 was identified in a large 
Arabidopsis phospho-proteasome profiling study (PhosPhAt database, version 4.0) 
(Heazlewood et al. 2008), making it unlikely that S121 or S122 would act redundantly with 
S123.  
Since S123 is situated in the JID of MYC2 phosphorylation of S123 might prevent MYC2-
JAZ binding consistent with the idea that absence of EDS1 leads to phosphorylation and 
consequently to lost JAZ binding. To test this further I created phospho-dead MYC2S123A 
and phospho-mimic MYC2S123D variants which both retained interaction with JAZ9 and 
JAZ10 similar to MYC2WT level (Figure 2.16). Again, it is possible that other JAZ proteins 
are involved. Also, MYC2S123A/D interacted with EDS1 family members resembling 
MYC2WT, indicating that phosphorylation status of S123 is not important for these protein-
protein interactions (Figure 2.15). 
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With nLC-MS/MS one can also test for other PTMs such as ubiquitination or acetylation. 
However, this increases the experimental and analytical efforts drastically. The advantage of 
a high-resolution methods like nLC-MS/MS is the capture of more transient, single residue 
changes. While we know very little about the functional implications of TF acetylation 
(Pireyre et al. 2015), ubiquitination is rather well understood (Sharma et al. 2016, Adams et 
al. 2018). Commonly, polyubiquitinated proteins are subject to 26S proteasomal 
degradation. Monoubiquitination on the other hand can be a means to regulate protein 
activity independent of 26S proteasomal degradation enhancing both, positive and negative 
outputs (Geng et al. 2012). The existence of deubiquitinating enzymes like UBP12 and 
UBP13 supports a transient, proteasome independent role of (mono)ubiquitination, also with 
relevance for MYC2 regulation (Jeong et al. 2017). 
EDS1 family members are highly conserved among flowering plants (Wagner et al. 2013) 
and so is JA signalling (Thaler et al. 2012). If S123 were of functional importance one 
would expect it to be phylogenetically conserved. As Figure 2.14E shows S123 was partially 
conserved across tested species, supporting an important role in many, though not all 
species. How the respective MPK-target sites are conserved across these species still needs 
to be addressed. 
3.2.4 EDS1 does not promote MYC2S123A transactivation activity on 
VSP1 
Next, I tested whether EDS1 could still promote MYC2S123A/D transactivation activity. While 
MYC2S123A/D resembled MYC2WT activity in promoting LOX3 expression, VSP1 was not 
promoted by EDS1 phospho-dead MYC2S123A (Figure 2.17B). Two conclusions can be 
made: first, LOX3 and VSP1 differ in their expression profiles, supporting the notion that 
distinct MYC2 signalling branches are regulated differently by EDS1. Second, MYC2S123D 
was still promoted by EDS1, suggesting that phosphorylation of S123 is necessary for the 
EDS1 effect. For detailed analysis of MYC2S123A/D function I have transformed myc2-3 and 
myc2-3/eds1-2 Arabidopsis plants with 35S:SH-MYC2S123A and 35S:SH-MYC2S123D, 
respectively. Plants are being selected and will help to gain insights in MYC2S123A/D function 
in the context of EDS1 (i.e. in myc2-3 vs. myc2-3/eds1-2) and Pst avrRPS4 induced ETI. 
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3.2.5 The protein kinase EDR1 associates with MYC2 and PAD4 but is 
unlikely to regulate MYC2 phosphorylation 
Searching for an EDS1 associated kinase, I found that EDR1 interacts with MYC2 and with 
PAD4, making it an interesting candidate for functional studies (Figure 2.18 and 2.19). 
Interaction was independent of avrRPS4, supporting the notion that EDS1 effects MYC2 
independent of ETI induction. EDR1 was identified in a forward genetic screen for gain-of-
resistance mutants against Pst (Frye et al. 1998). Interestingly, edr1 hyper-resistant plants 
are not autoimmune and do not show constitutive expression of defence genes like PR1 
(Frye et al. 1998). Therefore, loss of EDR1 either primes plants for defence, or EDR1 is 
activated upon pathogen infection only. Further work showed that EDR1 antagonises SA 
dependent defence against the powdery mildew pathogen E. cichoracearum (Frye et al. 
2001) and more recently, the molecular mechanism underlying EDR1 repression was 
described (Zhao, et al. 2014). EDR1 suppresses the MKK4/MKK5-MPK3/MPK6 kinase 
cascade by binding to MKK4/MKK5, providing functional insights into how EDR1 works 
(Zhao, et al. 2014). 
In spite of EDR1 interaction with PAD4 and MYC2 in co-IP assays, I did not detect EDR1 
dependent changes in MYC2 phosphorylation on protein SDS-gels (Figure 2.20). Higher 
resolution methods like mass spectrometry will provide details about single residue 
modifications that cannot be observed on SDS gels. Furthermore, in vitro kinase activity 
assays using recombinant proteins expressed in E. coli could answer if EDS1 and/or PAD4 
regulate EDR1 kinase activity or other kinases in general.  
3.2.6 Finding genes of interest - how does EDS1 regulate 
phosphorylation? 
RNA-seq data analysis of genes involved in protein (de)phosphorylation, proteolysis, or ETI 
showed that some but not all tested genes were differentially regulated in an EDS1 
dependent manner. The receptor-like kinase FER (FERONIA) for instance is unchanged 
between WT and eds1-2 plants, but might be still worth testing as an EDS1 regulated kinase. 
FER phosphorylates MYC2 at more than a dozen residues, including S123 and MYC2 
phosphorylation leads to its destabilisation (Guo et al. 2018). Further, FER inhibits MYC2 
dependent JA pathway gene expression and restricts MYC2 promoted Pst virulence (Guo et 
al. 2018). With FER modulating MYC2 phosphorylation in bacteria challenged and 
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unchallenged conditions it is tempting to speculate that FER is being utilized by EDS1 to 
control MYC2 phosphorylation. S123 was phosphorylated in myc2-3/eds1-2 background 
only (Figure 2.14), which could be explained by EDS1 preventing FER activity. This could 
be tested by comparing MYC2 phosphorylation in WT plants with eds1, fer, and eds1/fer 
mutants.  
Alternatively, MPK6 is an interesting candidate gene. MPK6 has been reported function 
largely redundantly with MPK3 in promoting plant immunity both in PTI and ETI (Meng et 
al. 2013). Like FER, MPK6 was shown to phosphorylate MYC2S123 (Sethi et al. 2014) and 
earlier work demonstrated that MPK6 inhibits MYC2 dependent JA signalling (Takahashi et 
al. 2007). This is in line with the observation that COR represses MPK3/6 activity by 
inducing protein phosphatases that dephosphorylate MPK6 and render it less active (Mine et 
al. 2017). Our group addressed whether MPK3/6 kinase activity is EDS1 dependent. 
Preliminary results suggest that MPK3/6 are more active (i.e. phosphorylated) in eds1-2 
plants compared to WT in MOCK treatment, indicating repression of MPK3/6 by EDS1 
(Bhandari, D., personal communication). If EDS1 suppressed MPK3/6 mediated 
phosphorylation of S123, this would explain how EDS1 modulates MYC2 activity. 
Intriguingly, MPK3/6 are downstream targets of EDR1 (Zhao et al. 2014), providing new 
support for EDR1 involvement in this regulation. 
Ultimately, a functional connection between EDS1 and FER or MPK3/6 in phosphorylating 
MYC2 and its relevance to MYC2 transcriptional activity needs to be demonstrated. For 
instance it will be interesting to test whether EDS1 has general potential to change protein 
kinase activity. In context of interesting candidates, activity of FER and MPK3/6 with and 
without EDS1 could be tested in a recombinant system using protein expressed in E. coli. 
Further, genetic evidence by crossing kinase mutants to eds1-2 plants would be informative. 
Assuming that EDS1 antagonises phosphorylation of MYC2, phosphorylation will be 
enhanced in eds1-2 mutants and lost in double mutants of eds1-2 with the functional kinase. 
Because mpk3/6 double mutants are lethal conditional loss-of-function mutants exist and 
could be used (Wang et al. 2007, Wang et al. 2008). 
A final remark regarding the shown RNA-seq data is that naturally, genes with high 
expression changes between WT and eds1-2 plants seem most interesting. However, as I 
show in this work and others have shown before, gene expression often does not correlate 
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with protein activity making it possible that even transcriptionally unchanged genes 
represent useful candidates to test. 
The regulatory network shown in Figure 3.1 connects data presented in this and other studies 
in order to explain the observed EDS1-MYC2 regulation. Here, I assume EDS1 to be “non-
activated”, i.e. in non-triggered conditions. As EDS1 promoted MYC2WT, but not JAZ 
uncoupled MYC2s in transient transactivation assays (Figure 2.4, 2.5), I propose that EDS1 
releases MYC2, directly or indirectly, from JAZ suppression. If this occurs by competitive 
binding, or by other means, and which JAZ proteins are involved remains to be tested. 
Further, I could show that MYC2S123 is phosphorylated in absence of EDS1 (Figure 2.14). 
MPK6 phosphorylates MYC2 at S123 (Sethi et al. 2014) and inhibits its transactivation 
activity (Takahashi et al. 2007). If S123 is the only phosphorylation site and thus the 
decisive one for MPK6 dependent regulation is unclear. Nevertheless, this raises the 
possibility that EDS1 enhances MYC2 transactivation activity by dampening MPK6 
activity, possibly via EDR1. This is supported by low levels of phosphorylated MPK6 in 
MOCK treated WT plants, compared to eds1-2 plants (Bhandari, D., personal 
communication, preliminary). This aspect needs further testing, as MYC2S123A/D LOX3 
transcription was still promoted by EDS1 (Figure 2.17A), but EDS1 did not enhance 
MYC2S123A dependent VSP1 expression (Figure 2.17B). A possible explanation for this 
would be different regulatory mechanisms for LOX3 and VSP1 signalling by MYC2. 
Alternatively, EDS1 could act via another, unknown component (Figure 3.1, “FACTOR 
X”). Figure 2.21 illustrates EDS1 dependent candidate genes that are involved in protein 
phosphorylation and/or plant immunity and might be worth testing.  
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Figure 3.1 Scheme illustrating EDS1 regulation of MYC2 transactivation activity in pathogen 
unchallenged conditions. MYC2 is repressed via MPK6 dependent phosphorylation and JAZ 
protein binding. The observed promotion of MYC2 transactivation activity as measured by LOX3 
and VSP1 transcript can be explained by EDS1 inhibiting MPK6 or JAZ activity. If EDR1 is 
connected to the EDS1 regulation of MYC2, directly or indirectly, is unclear. Alternatively, a so far 
unknown “FACTOR X” could be involved. Dashed lines represent hypothesised or preliminary 
connections. P: phosphorylation 
 
One mode of MYC2 regulation that I haven’t addressed in my work is the relationship of 
MYC2 and MED25. MED25 is a subunit of the MEDIATOR complex that links DNA-
associated TFs to RNA-polymerase II, thereby steering gene transcription (An et al. 2017, 
Kazan 2017). MYC2 relies on MED25 binding for its transactivation activity. Interestingly, 
JAZ proteins bind MED25, too. This leads to competitive binding to MED25 and allows 
JAZ proteins to repress MYC2 via MED25 (Kazan 2017). My colleague Dacheng Wang 
investigated whether EDS1 family proteins interfere with MYC2-MED25 binding and if so, 
if this has functional implications. He showed that EDS1 or PAD4, but not SAG101 interact 
with MED25 in Arabidopsis protoplasts, but this interaction did not affect MYC2 binding to 
MED25, suggesting distinct interaction motifs (Wang, D., personal communication). I 
concluded that EDS1 most likely does not regulate MYC2 by directly interfering with 
MYC2-MED25 interaction. Rather, EDS1 might release MED25 and promote MYC2 
indirectly by sequestering JAZ proteins. 
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3.3 SA-JA crosstalk in plant immunity 
This study needs to be considered in the context of hormonal crosstalk during plant 
immunity. By the end of the last century it became increasingly clear that crosstalk between 
certain phytohormones provides a means for the plant to fine-tune and prioritise defence 
pathways (Reymond et al. 1998). Now, the concept of hormonal crosstalk is well-established 
and all known phytohormones take part in fine-tuning the plant’s immune response (Robert-
Seilaniantz et al. 2011, Pieterse et al. 2012). Traditionally, the crosstalk between SA and JA 
pathways has received the most attention in context of plant-microbe/insect interactions 
although it is still unclear whether the evolution of SA-JA crosstalk goes along with 
adaptive advantages for the plant (Thaler et al. 2012). The common notion is that SA mainly 
prevents growth of microbial (hemi-) biotrophic pathogens. By contrast, JA signalling 
primarily counteracts necrotrophic pathogens and herbivores (Glazebrook 2005). The 
molecular basis for SA and JA pathway signalling is well understood and described in 
Introduction (section 1.4 and 1.5). Despite, or maybe because of our sound knowledge of SA 
and JA signalling, a major conceptual question remains: how do these two pathways coexist 
and mutually regulate each other in context of plant immunity, while maintaining highly 
specific, yet functionally diverse outputs? 
First, I will focus on the SA portion of SA-JA crosstalk. Spoel et al. were among the first to 
identify a molecular player of the SA-JA crosstalk in context of Pst infection. Upon 
infection, SA levels rise and induce PR1. This is accompanied by decreased JA levels and 
reduced LOX2 and VSP1 transcript. The novel finding was that NPR1, the key SA signal 
transducer, was required for this crosstalk (Spoel et al. 2003). Later, it was found that 
infection with (hemi-) biotrophic Pst renders plants more susceptible to the necrotrophic 
Alternaria brassicicola, providing further functional proof of NPR1 dependent SA-JA 
crosstalk (Spoel et al. 2007). Another component in SA-JA crosstalk regulation is MPK4. 
Mpk4 mutants were autoimmune, and with high SA accumulation and PR1 expression, 
failed to induce the JA marker PDF1.2 (Petersen et al. 2000). Multiple other components 
have been implicated in SA-JA crosstalk, too, including WRKY TFs, redox regulators like 
GRX480 (GLUTAREDOXIN 480), TGA (TGACG MOTIF-BINDING PROTEIN) TFs, the 
fatty acid desaturase SSI2 (SUPPRESSOR OF SA INSENSITIVE 2), and the catalase CAT2 
(CATALASE 2) (Pieterse et al. 2012, Yuan et al. 2017). In ETI specifically, our group 
showed that EDS1/PAD4 protect and boost the SA pathway in part by repressing MYC2 
(Cui et al. 2018). The described components that establish the SA-JA crosstalk indicate that 
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this mutual regulation occurs downstream of hormone accumulation. This is further 
supported by work showing that even though SA targets JA biosynthesis genes, SA 
represses PDF1.2 and VSP2 in JA biosynthesis deficient aos/dde2 plants (Leon-Reyes et al. 
2010). Consistent with this, the JA responsive TF ORA59 was identified as a target for SA 
to repress JA pathway genes (Van der Does et al. 2013). Overall, the molecular mechanisms 
by which SA pathways dampen JA signalling are manifold and mirror the high complexity 
of hormone signalling networks in Arabidopsis. 
Interestingly, JAZ proteins have not been found to be directly involved in SA-JA crosstalk, 
but present an integrative node for JA crosstalk with other plant hormones like ABA and GA 
(Chini et al. 2016). 
How the JA pathway represses SA outputs is less well understood. Our group could show 
that on the molecular level MYC2 attenuates EDS1 expression. This effect depends on 
MYC2 binding to the EDS1 promoter, suggesting transcriptional rather than translational 
regulation (Qiu et al., in prep.).  
Additionally, numerous examples show that the SA-JA antagonism can be exploited by 
(hemi-) biotrophic pathogens such as Pst. By producing COR, a functional mimic of 
bioactive JA-Ile, Pst inhibits the SA pathway, resulting in enhanced bacterial virulence 
(Brooks et al. 2004, Brooks et al. 2005, Zheng et al. 2012). Besides small molecules like 
COR, Pst also produces effector proteins, which act as virulence factors. One such effector 
is HopX1 which was shown to initiate JA signalling by degrading JAZ repressors, providing 
an alternative means for Pst to dampen the plant’s SA response (Gimenez-Ibanez et al. 
2014). Another example of effector mediated virulence is HopBB1. Once secreted into the 
plant cell HopBB1 interacts with JAZ3 and the JA repressor TCP14. This causes TCP14 
degradation by the SCFCOI1 degradation complex, de-repression of JA pathway signalling, 
and ultimately enhanced pathogen virulence (Yang et al. 2017). An overview of bacterial 
effectors and their respective impact on hormone signalling was provided by Kazan and 
Lyons (Kazan et al. 2014). 
While not the focus of this discussion, it is worth mentioning that beneficial microbes 
evolved distinct means to manipulate plant defence, including SA-JA crosstalk (Pieterse et 
al. 2014).  
Besides mutually negative regulation, neutral and positive correlations in SA-JA crosstalk 
have been observed as well (Schenk et al. 2000, van Wees et al. 2000, Mur et al. 2006, Liu 
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et al. 2016). Recently, Mine et al. (2017) identified an incoherent feed forward loop that 
allows JA to promote or attenuate SA accumulation dependent on the immune status of the 
plant. The authors showed that JA induces expression of EDS5, a crucial gene for SA 
accumulation, via MYC2, while simultaneously dampening expression of PAD4, a positive 
regulator of EDS5 expression. With this mechanism the plant is able to limit SA dependent 
growth repression in absence of pathogens and to initiate robust SA accumulation during 
PTI (Mine et al. 2017). 
The seemingly contradictory observations that JA accumulation coincides with SA 
accumulation could be explained by segmenting SA-JA occurrence into spatially distinct 
domains. Indeed, a recent study showed spatio-temporal dynamics of the SA marker gene 
PR1 and the JA marker gene VSP1 during ETI in Arabidopsis (Betsuyaku et al. 2017). The 
concentric pattern of SA accumulation in the centre and JA accumulation at the periphery of 
the infection site separates contributions of the SA and JA pathways during ETI and allows 
spatially restricted, domain specific immune signalling (Betsuyaku et al. 2017). 
Given this multifaceted and complex relationship between the two pathways, general 
statements like “SA and JA antagonise each other” are often oversimplifying. The nature of 
SA-JA crosstalk usually depends on i) time and duration of elicitation, ii) sequence of 
triggers, and iii) strength of stimulus and is therefore highly dynamic and context specific 
(Koornneef et al. 2008, Leon-Reyes et al. 2010). This multi-layered, finely tuneable 
regulation makes sense since plants usually face a plethora of harmful organisms. Proper 
timing and prioritisation of responses determine the best use of limited resources and the 
most promising strategy of defence. Taken together, this explains how two distinct, yet 
connected pathways can coexists and mutually regulate each other over the plant’s lifespan.  
As mentioned, we know relatively little about the molecular mechanisms underlying the SA-
JA crosstalk. This study, together with the latest work by colleagues in the group, 
illuminates the molecular basis by connecting the SA pathway component EDS1 with the JA 
master TF MYC2. EDS1 (and PAD4) antagonise MYC2 in ETI, thereby ensuring a strong 
SA response during pathogen infection (Cui et al. 2018). Conversely, MYC2 dampens EDS1 
expression by binding the EDS1 promoter, making the plant more susceptible to Pst 
infection (Qiu et al., in prep.). Here, I interrogated how EDS1 modulates MYC2 activity 
mechanistically. Collectively, my data argue for EDS1 control of MYC2 by directly or 
indirectly releasing MYC2 from JAZ inhibition. Further, I provide evidence of EDS1 
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dependent MYC2 phosphorylation. As these are partially contradictory observations, it will 
be crucial to test the biological relevance of the observed molecular relationships. With the 
previously described highly diverse regulatory network of SA-JA crosstalk, multiple, 
synergistic and antagonistic connections of EDS1 and MYC2 seem plausible.  
 
3.4 Perspectives 
Our group recently established an antagonistic relationship between EDS1/PAD4 complexes 
and the JA key TF MYC2. By antagonizing bacterial COR-stimulated MYC2 transcriptional 
induction of JA pathway genes EDS1/PAD4 restrict bacterial virulence during TNL-ETI 
(Cui et al. 2018). 
In this study I identify a positive connection between MYC2 and EDS1 with EDS1 
promoting MYC2 transactivation activity. Functionally, this involves EDS1 dependent 
regulation of JAZ proteins (indirect evidence) and protein phosphorylation. For a more 
detailed understanding and especially for biological relevance however additional 
experiments are necessary.  
Assuming that EDS1 releases MYC2 from JAZ suppression it would be interesting to see 
whether EDS1 shares any surface structure with (certain) JAZ proteins, which might explain 
competition with JAZs for MYC2 binding. Preliminary analysis by my colleague Deepak 
Bhandari suggests that this is not the case, but more detailed analysis will be needed to 
answer this definitely (Bhandari, D., personal communication). Also, it is worth testing 
EDS1 interaction with further JAZ proteins. To address functional relevance of promoted 
MYC2 activity by EDS1 stable transgenic Arabidopsis lines are needed. For this I am 
generating transgenic lines expressing C-terminally 3xflag tagged MYC2 or JAZ uncoupled 
MYC2s, driven by its own promoter (pMYC2:MYC2-flag or pMYC2:MYC2s-flag) in myc2-3 
or myc2-3/eds1-2 background. By testing transcript, protein, and target gene expression 
before and after Pst avrRPS4 infection this will tell whether EDS1 is affecting the MYC2-
JAZ regulation and to what extent pathogen challenge influences this. 
The nLC-MS/MS experiment described in Figure 2.14 focused on phosphorylation as a 
putatively changed PTM by EDS1. With more analytical power and time one could rather 
easily test for SUMOylation, ubiquitination, or acetylation and resolve even single residue 
modifications that might be missed by other, more crude methods. 
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With MYC2S123 phosphorylated in an EDS1 dependent manner, it will be interesting to test 
whether S123 phosphorylation is important for MYC2 function in context of EDS1 
signalling. As for MYC2 and MYC2s, I am generating transgenic lines expressing 
pMYC2:MYC2S123A-flag or pMYC2:MYC2S123D-flag in myc2-3 or myc2-3/eds1-2 
background. This will allow to interrogate MYC2 activity in planta in pathogen challenged 
and unchallenged conditions.  
Further, it will be interesting to test whether EDS1 is capable of directly modulating kinase 
activities of potential strong candidate protein kinases such as EDR1, FER, and MPK6, in a 
recombinant system. If so, this will also tell whether EDS1 requires additional components 
for this regulation or not. Also, predicting the likelihood of MYC2S123 being a MPK target 
site will be useful for further characterisation. 
The complexity of the EDS1 and the MYC2 node respectively complicates identification of 
biologically relevant regulation. Providing evidence for functionally relevant promotion of 
MYC2 transactivation signalling by EDS1, whether through JAZ interference or protein 
phosphorylation control is therefore of highest priority. 
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4 Materials and Methods 
Materials and methods are separated into two parts. Section 4.1 lists materials used in this 
work including plant lines, pathogen and bacterial strains, antibodies, chemicals, enzymes, 
media, etc. Experimental procedures and peculiarities are described in the second part, 4.2. 
4.1 Materials 
4.1.1 Plant Materials 
The Arabidopsis thaliana lines used in this study are listed in table 1. 
Table 1 - Arabidopsis thaliana lines used in this work 
Genotype Accession Reference 
WT Col-0 
Dangl lab, University of North Carolina, 
NC, USA 
edr1 Col-0 (Frye et al. 1998) 
eds1-2 Col-0/(Ler)* (Bartsch et al. 2006) 
eds1-2/pad4-1/sag101-2 Col-0 Parker lab, MPIPZ, Cologne 
myc2-3 Col-0 (Shin et al. 2012) 
myc2-3/eds1-2 Col-0 Parker lab, MPIPZ, Cologne 
myc234 Col-0 (Fernandez-Calvo et al. 2011) 
pMYC2:MYC2-flag Col-0 (Hou et al. 2010) 
pMYC2:MYC2-flag/eds1-2 Co-0 Parker lab, MPIPZ, Cologne 
* Ler eds1-2 allele introgressed into Col-0 background, 8th backcrossed generation, referred 
to as "eds1-2" in this work 
For Agrobacterium tumefaciens dependent transient expression assays I used Nicotiana 
benthamiana 310A plants from the seed stock of MPIPZ, Cologne, GER.  
4.1.2 Pathogen Strains 
Throughout this work Pseudomonas syringae pv. tomato DC3000 (Pst) was used as a hemi-
biotrophic pathogen strain. The strain was either transformed with the empty vector pVSP61 
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or with pVSP61 carrying avrRPS4, an effector gene from Pseudomonas syringae pv. pisi 
(Hinsch et al. 1996). 
The coronatine lacking strain Pst DC3000 ∆cor was obtained from Renier van der Hoorn 
(MPIPZ). To generate Pst avrRPS4 ∆cor, the pVSP61-avrRPS4 plasmid was transformed 
into Pst ∆cor.  
4.1.3 Bacterial Strains 
An overview of bacteria used in this study is given in table 2. 
Table 2 - Bacterial strains used in this work 
Species Strain Genotype 
E.coli DB3.1 F- gyrA462 endA Δ(sr1-recA) mcrB mrr hsdS20 (rB- 
mB-) supE44 ara14 galK2  
lacY1 proA2 rpsL20 (StrR) xyl5 λ- leu mtl1  
E.coli DH5α  F- Φ80dlacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 
endA1 hsdR17(rk -, mk+) phoA supE44 λ- thi-1 gyrA96 
relA1 
E.coli DH10b F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 deoR recA1 endA1 araΔ139 Δ(ara, leu)7697 
galU galK λ- rpsL (StrR) nupG  
A. tumefaciens GV3101 pMP90RK (Deak et al. 1986) 
4.1.4 Antibiotics 
Table 3 shows antibiotics used in this study. Aqueous stocks were sterile filtered before use. 
Table 3 - Antibiotic stock solutions 
Name stock concentration 
(mg/ml) 
working concentration 
(µg/ml) 
solved 
in 
Ampicillin 100 100 ddH2O 
Carbenicillin 100 50 ddH2O 
Kanamycin 50 25 ddH2O 
Gentamycin 25 25 (Pst)/15 (Agrobac.) ddH2O 
Rifampicin 40 100 DMSO 
Spectinomycin 100 100 ddH2O 
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4.1.5 Antibodies 
Antibodies used in this study are listed in table 4. 
Table 4 - Antibodies 
Antibody Source Dilution Supplier Group 
α-flag rabbit polyclonal 1:5000 Sigma-Aldrich primary 
α-GFP rabbit monoclonal 1:5000 Cell Signaling 
Technology 
primary 
α-HA rabbit monoclonal 1:5000 Cell Signaling 
Technology 
primary 
α-myc rabbit monoclonal 1:5000 Cell Signaling 
Technology 
primary 
α-Ubiquitin rabbit polyclonal 1:1500 Cell Signaling 
Technology 
primary 
α-rabbit IgG-HRP goat polyclonal 1:5000 Sigma-Aldrich secondary 
 
4.1.6 Chemicals 
All chemicals met laboratory use purity and were obtained by various laboratory suppliers 
including Merck (Darmstadt, GER), Roth (Karlsruhe, GER), SERVA (Heidelberg, GER), 
Sigma-Aldrich (Hamburg, GER), ThermoFisher (MA, USA), and VWR (Langenfeld, GER). 
 
4.1.7 Enzymes 
4.1.7.1 Restriction Enzymes 
For DNA digestion restriction enzymes from either New England Biolabs (NEB, Frankfurt, 
GER) or ThermoFisher Scientific (MA, USA) were used to the manufacturer's 
recommendations.  
4.1.7.2 DNA Polymerases 
Different DNA Polymerases were used according to cloning purpose and complexity. An 
overview is given in table 5. 
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Table 5 - DNA Polymerases used in this work 
Name Purpose Supplier 
Phire II standard PCR ThermoFisher 
Phusion HF HF, proofreading for cloning ThermoFisher 
Takara PrimeStar HF, proofreading, for GC-rich templates CloneTech 
 
4.1.7.3 Other enzymes 
Other enzymes used include T4 DNA ligase (ThermoFisher), cDNA Synthesis SuperMix 
(Bimake, Munich, GER), Gateway® pENTR™/D-TOPO™ Kit (ThermoFisher), Gateway® 
LR Clonase® II Enzyme Mix (ThermoFisher), PhosSTOP™ Phosphatase Inhibitor (Merck, 
Darmstadt, GER), Lambda Protein Phosphatase (NEB), Cellulase Onozuka R-10, and 
Macerozyme R-10 (both SERVA, Heidelberg, GER). 
 
4.1.8 Oligonucleotides 
Primers are given in table 6. For regular oligo design primer3 (http://bioinfo.ut.ee/primer3/) 
was used while SDM primer were created by the primerX 
(http://www.bioinformatics.org/primerx). Oligonucleotides were ordered at Sigma-Aldrich 
(Hamburg, GER). Lyophilised primer were resuspended in ddH2O to 100 µM stock 
concentration and diluted 1:10 to reach a working concentration of 10 µM. 
 
Table 6 - Oligonucleotides 
Name Orientation Sequence 5' - 3' purpose 
ACTIN fw ATGGAAGCTGCTGGAATCCAC qRT-PCR 
ACTIN rv TTGCTCATACGGTCAGCGATA qRT-PCR 
AP1 fw CTCTCTCATCAGCCATCTC qRT-PCR 
AP1 rv AACGGGTTCAAGAGTCAGTTC qRT-PCR 
EDS1 fw AGATTATTCAGGTGATCGAGCA qRT-PCR 
EDS1 rv TTTATGGGCTTGACACTTTGG qRT-PCR 
IAA19 fw GGTGTGGCCTTGAAAGATGG qRT-PCR 
IAA19 rv TCTCAACCTCTTGCATGACTCT qRT-PCR 
ICS1 fw TTCTGGGCTCAAACACTAAAAC qRT-PCR 
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ICS1 rv GGCGTCTTGAAATCTCCATC qRT-PCR 
LFY fw TCAGGTACGCGAAGAAATCA qRT-PCR 
LFY rv GAAGCTTCTTCGTCTAGGCA qRT-PCR 
LOX3 fw CGCGAGTTTCATCTCCCATC qRT-PCR 
LOX3 rv CGCATCTCCTGTCCAAATCG qRT-PCR 
MYC2 fw GAACGACCCGTCTATGTG qRT-PCR 
MYC2 rv TTCGGTTATTGTGCTTGA qRT-PCR 
ORA59 fw GCCGAGATAAGAGACTCAACG qRT-PCR 
ORA59 rv AGATTCTTCAACGACATCCGC qRT-PCR 
PBS3 fw ACACCAGCCCTGATGAAGTC qRT-PCR 
PBS3 rv CCCAAGTCTGTGACCCAGTT qRT-PCR 
VSP1 fw TCATACTCAAGCCAAACGG qRT-PCR 
VSP1 rv ATCCTCAACCAAATCAGC qRT-PCR 
MYC2_S123A fw GGAGATCGAGTGCTCCGCCGTTTTC SDM 
MYC2_S123A rv GAAAACGGCGGAGCACTCGATCTCC SDM 
MYC2_S123D fw GGAGATCGAGTGATCCGCCGTTTTC SDM 
MYC2_S123D rv GAAAACGGCGGATCACTCGATCTCC SDM 
 
4.1.9 Vectors 
Vectors used or generated in this work are listed in table 7. 
Table 7 - Vectors 
Vector Notes 
pENTR-EDR1 Gateway® entry plasmid that contains CDS of EDR1 
with stop codon from Col-0 
pENTR-gEDS1 Gateway® entry plasmid that contains genomic EDS1 
without stop codon from Ler-0 
pENTR-gEDS1LLIF Gateway® entry plasmid that contains mutated genomic 
EDS1 without stop codon from Ler-0, described in 
(Wagner et al. 2013) 
pENTR-JAZ9 Gateway® entry plasmid that contains CDS of JAZ9 with 
stop codon from Col-0 
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pENTR-JAZ9 Gateway® entry plasmid that contains CDS of JAZ9 
without stop codon from Col-0 
pENTR-JAZ10 Gateway® entry plasmid that contains CDS of JAZ10 
with stop codon from Col-0 
pENTR-JAZ10 Gateway® entry plasmid that contains CDS of JAZ10 
without stop codon from Col-0 
pENTR-MYB33 Gateway® entry plasmid that contains CDS of MYB33 
with stop codon from Col-0 
pENTR-MYC2D105N 
named super-MYC2 (MYC2s) 
Gateway® entry plasmid that contains CDS of mutated 
MYC2 with stop codon from Col-0, described in 
(Goossens et al. 2015) 
pENTR-MYC2S123A Gateway® entry plasmid that contains CDS of mutated 
MYC2 with stop codon from Col-0 
pENTR-MYC2S123D Gateway® entry plasmid that contains CDS of mutated 
MYC2 with stop codon from Col-0 
pENTR-PAD4 Gateway® entry plasmid that contains CDS of PAD4 
with stop codon from Ler-0 
pENTR-PIF4 Gateway® entry plasmid that contains CDS of PIF4 
without stop codon from Col-0 
pENTR-SAG101 Gateway® entry plasmid that contains CDS of SAG101 
with stop codon from Ler-0 
pENTR-SOC1 Gateway® entry plasmid that contains CDS of SOC1 
without stop codon from Col-0 
pXCSG-mYFP-GW Binary Gateway® destination vector for expression of a 
fusion protein under control of 35S promoter with a C-
terminal mYFP tag 
pXCSG-gEDS1-mYFP  
 
Binary Gateway® destination vector for expression of 
genomic EDS under control of 35S promoter with a C-
terminal mYFP tag 
pXCSG-gEDS1LLIF-mYFP  
 
Binary Gateway® destination vector for expression of 
mutated genomic EDS under control of 35S promoter 
with a C-terminal mYFP tag 
pXCSG-JAZ9-mYFP  Binary Gateway® destination vector for expression of 
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JAZ9 under control of 35S promoter with a C-terminal 
mYFP tag 
pXCSG-JAZ10-mYFP  Binary Gateway® destination vector for expression of 
JAZ10 under control of 35S promoter with a C-terminal 
mYFP tag 
pXCSG-PAD4-mYFP  
 
Binary Gateway® destination vector for expression of 
PAD4 under control of 35S promoter with a C- terminal 
mYFP tag  
pXCSG-PAD41-300-mYFP  
 
Binary Gateway® destination vector for expression of 
truncated PAD4 under control of 35S promoter with a C- 
terminal mYFP tag  
pXCSG-SAG101-mYFP  
 
Binary Gateway® destination vector for expression of 
SAG101 under control of 35S promoter with a C- 
terminal mYFP tag 
pXCSG-YFP-mYFP  Binary Gateway® destination vector for expression of 
YFP (with stop codon) control of 35S promoter with a C-
terminal mYFP tag  
pENSG-mYFP-GW Binary Gateway® destination vector for expression of a 
fusion protein under control of 35S promoter with a N-
terminal mYFP tag 
pENSG-mYFP-EDR1  Binary Gateway® destination vector for expression of 
EDR1 under control of 35S promoter with a N-terminal 
mYFP tag 
pENSG-mYFP-JAZ9  Binary Gateway® destination vector for expression of 
JAZ9 under control of 35S promoter with a N-terminal 
mYFP tag 
pENSG-mYFP-JAZ10  Binary Gateway® destination vector for expression of 
JAZ10 under control of 35S promoter with a N-terminal 
mYFP tag 
pXCSG-3xflag-GW Binary Gateway® destination vector for expression of a 
fusion protein under control of 35S promoter with a C-
terminal 3xflag tag  
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pXCSG-gEDS1-flag  
 
Binary Gateway® destination vector for expression of 
genomic EDS1 under control of 35S promoter with a C-
terminal 3xflag tag 
pXCSG-gEDS1LLIF-flag 
 
Binary Gateway® destination vector for expression of 
mutated genomic EDS1 under control of 35S promoter 
with a C-terminal 3xflag tag 
pXCSG-JAZ9-flag  
 
Binary Gateway® destination vector for expression of 
JAZ9 under control of 35S promoter with a C-terminal 
3xflag tag 
pXCSG-JAZ10-flag  
 
Binary Gateway® destination vector for expression of 
JAZ10 under control of 35S promoter with a C-terminal 
3xflag tag 
pXCSG-PAD4-flag  
 
Binary Gateway® destination vector for expression of 
PAD4 under control of 35S promoter with a C-terminal 
3xflag tag 
pXCSG-MYC2-flag Binary Gateway® destination vector for expression of 
MYC2 under control of 35S promoter with a C-terminal 
3xflag tag 
pXCSG-GUS-flag Binary Gateway® destination vector for expression of 
GUS under control of 35S promoter with a C-terminal 
3xflag tag 
pENS-StrepII-3xHA (SH)-GW  Binary Gateway® destination vector for expression of a 
fusion protein under control of 35S promoter with an N-
terminal StrepII-3xHA tag 
pENS-SH-EDR1 
 
Binary Gateway® destination vector for expression of 
EDR1 under control of 35S promoter with an N-terminal 
StrepII-3xHA tag 
pENS-SH-MYB33 Binary Gateway® destination vector for expression of 
MYB33 under control of 35S promoter with an N-
terminal StrepII-3xHA tag 
pENS-SH-MYC2  
 
Binary Gateway® destination vector for expression of 
MYC2 under control of 35S promoter with an N-terminal 
StrepII-3xHA tag 
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pENS-SH-MYC2D105N 
named super-MYC2 (MYC2s) 
Binary Gateway® destination vector for expression of 
mutated MYC2 under control of 35S promoter with an N-
terminal StrepII-3xHA tag  
pENS-SH-MYC2S123A  
 
Binary Gateway® destination vector for expression of 
mutated MYC2 under control of 35S promoter with an N-
terminal StrepII-3xHA tag  
pENS-SH-MYC2S123D 
 
Binary Gateway® destination vector for expression of 
mutated MYC2 under control of 35S promoter with an N-
terminal StrepII-3xHA tag  
pENS-SH-PIF4 
 
Binary Gateway® destination vector for expression of 
PIF4 under control of 35S promoter with an N-terminal 
StrepII-3xHA tag 
pENS-SH-SOC1 
 
Binary Gateway® destination vector for expression of 
SOC1 under control of 35S promoter with an N-terminal 
StrepII-3xHA tag 
pENS-SH-YFP  
 
Binary Gateway® destination vector for expression of 
YFP under control of 35S promoter with an N-terminal 
StrepII-3xHA tag  
pXCSG-3xHA-GW  Binary Gateway® destination vector for expression of a 
fusion protein under control of 35S promoter with an C-
terminal 3xHA tag 
pXCSG-avrRPS4-3xHA Binary Gateway® destination vector for expression of 
avrRPS4 under control of 35S promoter with an C-
terminal 3xHA tag  
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4.1.10 Media 
All media were sterilised by autoclaving at 121 °C for 20 min. Heat sensitive additives like 
antibiotics were added once the media cooled to approximately 50 °C.  
 
Agrobacterium tumefaciens media  
YEB   
Beef extract 5.0 g/L 
Yeast extract 1.0 g/l 
Peptone 5.0 g/l 
Sucrose 5.0 g/l  
1M MgSO4 2.0 ml/l  
pH 7.2  
For YEB agar plates 1.5 % (w/v) agar was added.  
 
Escherichia coli media  
LB (Luria-Bertani) broth  
Tryptone 10.0 g/l  
Yeast extract 5.0 g/l  
NaCl 5.0 g/l   
pH 7.0  
For LB agar plates 1.5 % (w/v) agar was added.  
 
 
Pseudomonas syringae media  
NYG broth  
Peptone 5.0 g /l 
Yeast extract 3.0 g/l 
Glycerol  20 ml/l  
pH 7.0  
For NYG agar plates (NYGA) 1.5 % (w/v) agar was added.  
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4.1.11 Buffers and Solutions 
Buffers and their components used in this work are summarised in table 8. 
Table 8 - Buffers and Components 
Application Buffer Components 
DNA extraction (quick 
and dirty) 
DNA extraction buffer 200 mM Tris pH 7.5, 250 mM 
NaCl, 25 mM EDTA pH 7.5, 0.5 % 
SDS 
DNA extraction (sucrose 
prep) 
sucrose solution 50 mM Tris pH 7.5, 300 mM NaCl, 
300 mM sucrose 
DNA electrophoresis 10x TAE running buffer 0.4 M Tris, 0.2 M acetic acid, 10 
mM EDTA, pH 8.5  
 6x DNA loading buffer 40 % (w/v) sucrose, 0.5 M EDTA, 
0.2 %(w/v) bromophenol blue  
 DNA ladder 10 %(v/v) 6× loading buffer, 5 
%(v/v) 1 kb DNA ladder 
(ThermoFisher)  
SDS-PAGE 10x Tris-glycine running 
buffer   
250 mM Tris, 1.92 M glycine, 1 
%(w/v) SDS  
 2x SDS sample buffer 
(Lämmli buffer) 
60 mM Tris pH6.8, 4 %(w/v) SDS, 
200 mM DTT, 20 %(v/v) glycerol, 
0.2 %(w/v) bromophenol blue  
Immunoblotting TBST buffer 10 mM Tris, 150 mM NaCl, 0.05 
%(v/v) Tween 20, pH 7.5  
 10x transfer buffer 250 mM Tris, 1.92 M glycine, 1 
%(w/v) SDS, 20 %(v/v) 
Methanol  
 Ponceau-S Dilution of ATX Ponceau 
concentrate (Fluka) 1:5 in ddH2O  
Protein Extraction  Extraction- and wash 50 mM Tris (PH7.5), 150 mM 
NaCl, 10 % (v/v) Glycerol, 2 mM 
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buffer EDTA, 5 mM DTT, Protease 
inhibitor (Roche, 1 tablet per 50 
mL), 0.1 % Triton  
Arabidopsis protoplast 
preparation 
Digestion enzyme solution 1.5% cellulose R10, 0.4% 
macerozyme R10 (SERVA), 0.4 M 
mannitol, 20 mM KCl, 20 mM 
MES (PH5.7), 55 °C for 10 min 
followed by cooling to room 
temperature before adding 10 mM 
CaCl2, 0.1% BSA (Sigma A-6793)  
 PEG 40 % (w/v) 
transformation solution 
4 g PEG 4000 (Sigma-Aldrich, 
#81240), 0.2 M mannitol, 0.1 M 
CaCl2   
 W5 wash buffer 154 mM NaCl, 125 mM CaCl2, 5 
mM KCl, 2 mM MES (pH 5.7)  
 MMg resuspension 
solution 
0.4 M mannitol, 15 mM MgCl2, 4 
mM MES (pH 5.7)  
N. benthamiana transient 
expression 
infiltration solution 10 mM MES, 10 mM MgCl2, 
pH5.6, 0.15 mM acetosyringone  
Pst infection infiltration solution 10 mM MgCl2 
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4.2 Methods  
4.2.1 Plant methods 
4.2.1.1 Maintenance and cultivation of Arabidopsis thaliana plants 
Arabidopsis seeds were sown on moist soil supplemented with 10 mg/l Confidor® WG 70 
(Bayer, GER) and vernalised in the dark for 48 h at 4 °C. After this, seeds for experiments 
were covered with a propagator lid and placed in growth chambers with the following 
conditions: 10 h light, 14 h dark, ~ 150 μmol m−2 s−1, 22 °C, 65 % humidity. Seeds that were 
sown for plant propagation or crossings were grown in "fast breeding" settings: 22 h light, 2 
h dark, ~ 150 μmol m−2 s−1, 22 °C, 65 % humidity. Propagator lids were removed 5 - 7 days 
after germination. For seed collection mature plants were wrapped in a breathable plastic 
bag and harvested once plants had dried completely. 
4.2.1.2 Agrobacterium tumefaciens mediated transformation of Arabidopsis 
("floral dip") 
To obtain stably transformed Arabidopsis plants I used the well-established "floral dip" 
method (Clough et al. 1998). Stems of Arabidopsis plants grown under the aforementioned 
fast breeding conditions were cut once after inflorescences set to promote the number of 
shoots. Ca. 5-week-old plants were then dipped in 5 % sucrose, 0.01 % Silwet L-77 solution 
containing the Agrobacteria (OD600 = 1.5). Inflorescences were submerged for 45 sec with 
gentle agitation, then dapped on tissue to remove excessive solution and covered in plastic 
bags for 24 h without direct exposure to light. After this the plastic bags were removed and 
plants were grown in the greenhouse.  
4.2.1.3 Crossing of Arabidopsis plants 
To cross genetically defined backgrounds, Arabidopsis plants were grown until 
inflorescence emergence. Flowers with immature pollen, but fully developed stigma were 
emasculated and received donor pollen via dabbing donor stamen onto each stigma. Cross-
pollinated stigmata were sealed in paper bags and left to set seeds. Progeny was then 
analysed for segregation and desired gene combinations.  
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4.2.1.4 Isolation of Arabidopsis mesophyll protoplasts 
For preparation of Arabidopsis mesophyll protoplasts I used an adapted version of the 
protocol published by the Sheen group (Yoo et al. 2007). Arabidopsis plants of defined 
genetic backgrounds were grown and leaves were harvested 4.5 weeks after sowing. Ca. 20 
leaves were stacked and cut on tissue with a razor blade into 1 mm thin stripes. Cut leaves 
were placed in enzyme solution (see section 4.1.11) immediately and vacuum infiltrated 
twice for 5 min each. The digestion mix was then incubated at RT for 3 h with gentle 
shaking (30 rpm). To isolate the protoplasts, the solution was filtered through a nylon mesh 
(100 µm), collected in a flacon tube and washed with the same volume W5 buffer. Cells 
were centrifuged at 100 g, RT, 1 min. The wash was repeated twice followed by incubating 
the cells on ice for 30 min. After this, protoplasts were spun down and resuspended in MMg 
solution to the desired volume (5x105 protoplasts/ml). 200 µl protoplasts were added to the 
prepared plasmid combinations, mixed, and transformed by adding 220 µl PEG 4000 
solution. Tubes were inverted 3 times and incubated at RT for 12 min before the 
transformation was stopped by adding 800 µl W5 buffer. Cells were centrifuged (100 g, RT, 
2 min), washed with 1 ml W5 buffer, and finally resuspended in 1 ml fresh W5 buffer. 
Samples were taken 14 h after transformation by either adding RNA extraction buffer, 
Lämmli buffer, or IP extraction buffer and processed accordingly. For Immunoprecipitation 
assays all volumes were scaled up 10 times. 
 
4.2.2 Bacterial methods 
4.2.2.1 E. coli 
In general, E. coli laboratory strains were grown at 37 °C in LB medium supplemented with 
the respective antibiotic to ensure plasmid maintenance. 
Transformation of chemically competent E. coli cells was performed as follows: 50 µl 
competent cells were thawed on ice and incubated with 2 - 10 ng plasmid DNA for 10 min 
on ice. The mixture was heat shocked using a water bath at 42 °C for 30 sec and was 
immediately put to ice for 2 min. After adding 700 µl LB medium, cells were incubated at 
37 °C and 200 rpm for 1 h to allow expression of the resistance cassette. Cells were then 
centrifuged (6000 g, 1 min) and resuspended in 200 µl of which 100 µl were plated on 
selective LB media plates. 
 
Materials and Methods 
 
 85 
4.2.2.2 A. tumefaciens 
Agrobacteria were grown in liquid or solid YEB medium with respective antibiotic 
resistance at 28 °C for 1 - 2 days.  
Agrobacteria were transformed via electroporation. Electro competent cells were incubated 
with 20 ng plasmid DNA for 10 min on ice before being transferred to a precooled 
electroporation cuvette (1 mm, Eurogentec, BE). The BioRad Gene Pulser Xcell™ with the 
following settings was used for electroporation. 25 μF, 2.5 kV, 5 ms, and 400 Ω. After 
pulsing, cells were supplied with 700 µl YEB medium immediately and incubated at 28 °C, 
200 rpm for 2 h to allow resistance cassette expression. To obtain single colonies, 50 µl of 
cells were plated on selective LB media plates. 
For Nicotiana benthamiana infiltration Agrobacteria were grown on plate overnight and 
resuspended in infiltration medium with an adjusted OD600 = 0.2. A needleless syringae was 
used to infiltrate the abaxial side of mature leaves. 
4.2.2.3 P. syringae 
Pseudomonas syringae strains were grown on selective NYGA plates at 28 °C for 2 days. 
Stock plates were kept for 2 weeks at 4 °C before being re-streaked.  
For infection experiments, bacteria were streaked on fresh plates and grown overnight 
before being resuspended in infiltration medium and infiltrated in the abaxial leaf side using 
a needleless syringae. General infection assays were performed by infiltrating Pst with an 
OD600  = 0.002. Samples were taken either 6 hpi or 24 hpi.  
For infection of plants for nLC-MS/MS analysis bacterial OD600 was adjusted to 0.1 and 
samples were taken at 6 hpi.  
After infiltration, plants were covered with a propagator lid for 6 h to ensure high humidity. 
In general, plants were always infiltrated at 10 a.m. to avoid influence by the circadian 
rhythm.  
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4.2.3 Biochemical methods 
4.2.3.1 Total protein extraction for immunoblot analysis 
Plant tissue was collected from 4-week-old Arabidopsis plants and snap frozen in liquid 
nitrogen followed by homogenisation with the Qiagen TissueLyser II (Qiagen, Hilden, 
GER). 50 - 100 µl Lämmli Buffer were added to the powder, vortexed, boiled at 95 °C for 
10 min, and centrifuged at 14000 rpm, 4 °C, 5 min. Supernatant was transferred to a new 
tube and used for immunoblot analysis or stored at -20 °C. 
4.2.3.2 Immunoprecipitation of transiently expressed protein  
For immunoprecipitation of proteins expressed in Arabidopsis protoplasts, cells were 
harvested by centrifugation (100 g, 1 min) followed by adding 600 µl extraction buffer 
directly to the cells. Samples were incubated on ice for 5 min with interspersed vortexing 
before being centrifuged for 2 min, 4 °C, 14000 rpm. 50 µl supernatant were taken as input 
sample. For immunoprecipitation, 12 µl of GFP-Trap or myc-Trap (Chromotek, Martinsried, 
GER) or ANTI-FLAG® M1 Gel (Sigma-Aldrich) were added to the supernatant and 
incubated on a rotating mixer for 2.5 h at 4 °C. After incubation, beads were spun down at 
2500 g at 4 °C for 2 min and washed 4 times with 1 ml extraction buffer. To elute the 
protein, 100 µl of Lämmli buffer were added to the beads and heated to 95 °C, 10 min with 
3 vortex steps. Finally, the eluted beads were collected at the bottom by centrifugation 
(14000 rpm, 4 °C, 1 min) and supernatant was transferred to a fresh tube and used for 
immunoblot analysis or stored at -20 °C. 
 
4.2.3.3 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
To separate proteins based on their size, the Mini-PROTEAN 3 SDS-PAGE system 
(BioRad) was used. Samples were extracted in Lämmli buffer and boiled at 95 °C for 10 
min. Samples were loaded on discontinuous, self-cast polyacrylamide gels (8 - 10 % for 
running gel, see table 9, and 6 % for stacking gel, see table 10) with 1.5 mm width. 
Electrophoresis took place in 1x Running buffer at 80 V for 15 min, followed by 120 V for 
70 - 90 min. As protein size marker 3 µl of the PageRuler™ Prestained Protein Ladder 
(ThermoFisher) were loaded. 
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Table 9 - Composition SDS PAGE running gels (for 4 1.5 mm gels) 
Component 8 % running gel 10 % running gel 
ddH2O 18.5 ml 15.7 ml 
1.5 M Tris-HCl pH 8.8 10 ml 10 ml 
10 % SDS 400 µl 400 µl 
30 % Acrylamide/Bis solution 29:1 10.7 ml 13.3 ml 
10 % APS 400 µl 400 µl 
TEMED 25 µl 25 µl 
 
Table 10 - Composition SDS-PAGE stacking gel (for 4 1.5 mm gels) 
Component 6 % stacking gel  
ddH2O 9 ml 
0.5 M Tris-HCl pH 6.8 4 ml 
10 % SDS 160 µl 
30 % Acrylamide/Bis solution 29:1 2.6 ml 
10 % APS 160 µl 
TEMED 25 µl 
 
4.2.3.4 Immunoblot analysis 
After successful SDS-PAGE proteins were transferred to a Hybond™-ECL™ nitrocellulose 
membrane (GE Healthcare, Freiburg, GER). For this the BioRad Mini Trans-Blot® cell 
system was employed. Gels were submerged for 10 min in ice-cold 1x transfer buffer and 
transfer cassettes were assembled to the manufacturer's instructions. Transfer was performed 
at 100 V for 70 min at 4 °C. To avoid high background signal after immunoblotting, 
membranes were blocked with 5 % (w/v) low-fat milk TBST solution for 60 min at RT on a 
shaker (50 rpm). Primary antibodies were diluted in 2 % (w/v) milk TBST solution (see 
table 4) and blocked membranes were incubated with the primary antibody over night at 4 
°C on a shaker (50 rpm). In the morning, membranes were washed 3 times with TBST (5 
min each) and then incubated with secondary antibody diluted in 2 % (w/v) milk TBST at 
RT for 60 min at 50 rpm. Primary antibodies bound by protein of interest were detected with 
a horseradish peroxidase (HRP) conjugated secondary antibody. After 4 washes with TBST 
(5 min each) membranes were supplied with the BioRad Clarity™ or Clarity Max™ 
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Western ECL Substrate. For highly abundant proteins Clarity substrate was used. For low 
abundance proteins a 1:1 ratio of Clarity™:Clarity Max™ or pure Clarity Max™ was used. 
Chemiluminescence was detected with the BioRad ChemiDoc™ XRS+ system. 
4.2.3.5 Immunoprecipitation for nLC-MS/MS 
Immunoprecipitation for nLC-MS/MS analysis was performed with tissue from stable 
transgenic Arabidopsis plants. For infiltration process please see chapter 4.2.2.3. For each 
sample 1 g of leaf tissue was collected and snap frozen. Tissue was then homogenised by 
using a pestle and mortar and afterwards by using the Precellys® Evolution Homogeniser at 
7500 rpm, 10 sec, 3 repeats (VWR, Darmstadt, GER). The powder was then resuspended in 
8 ml immunoprecipitation extraction buffer supplemented with PhosSTOP phosphatase 
inhibitor to prevent protein dephosphorylation. After 4 centrifugation steps (14000 rpm, 4 
°C, 10 min) I took 50 µl as input control and added 30 µl ANTI-FLAG® M1 Gel to each 
sample. Immunoprecipitation was performed for 3 h at 4 °C on a rotating mixer. Beads were 
collected by centrifugation at 2500 rpm, 4 °C, 2 min and washed with extraction buffer 4 
times. Protein was eluted from beads by adding 100 µl 0.1 % TFA (Trifluoroacetic acid), 
incubated 10 min at RT and neutralised by adding 100 µl 8 M urea. Samples were stored at  
-20 °C until further processing. 
 
4.2.3.6 nLC-MS/MS analysis 
Immunoprecipitated proteins in 4 M urea 50 mM Tris-HCl pH 8.5 were reduced with 
dithiothreitol, alkylated with chloroacetamide, and digested with trypsin (1:100) over night. 
Samples were desalted using stage tips with C18 Empore disk membranes (3 M, Neuss, 
GER) (Rappsilber et al. 2003). For data acquisition, dried peptides were re-dissolved in 10 
µL 2 % acetonitrile (ACN), 0.1% Trifluoroacetic acid (TFA). Samples were analysed using 
an EASY-nLC™ 1200 coupled to a Q Exactive™ Plus mass spectrometer (both 
ThermoFisher). Peptides were separated on 16 cm frit-less silica emitters (New Objective, 
0.75 µm inner diameter), packed in-house with reversed-phase ReproSil-Pur C18 AQ 1.9 
µm resin (Dr. Maisch). 5 µl of peptides were loaded on the column and eluted for 115 min 
using a segmented linear gradient of 5% to 95% solvent B (0 min: 5 % B; 0-5 min -> 5 % B; 
5-65 min -> 20 % B; 65-90 min -> 35 % B; 90-100 min -> 55 %; 100-105 min -> 95 %, 
105-115 min -> 95 %) (solvent A: 0 % ACN, 0.1 % formic acid (FA); solvent B: 80 % 
ACN, 0.1 % FA) at a flow rate of 300 nl/min. Mass spectra were acquired in data-dependent 
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acquisition mode with a TOP15 method by using an Orbitrap analyser with a mass range of 
300–1750 m/z at a resolution of 70,000 FWHM (Full Width at Half Maximum) and a target 
value of 3×106 ions. Precursors were selected with an isolation window of 1.3 m/z. HCD 
(High-energy collisional dissociation) fragmentation was performed at a normalised 
collision energy of 25. MS/MS spectra were acquired with a target value of 105 ions at a 
resolution of 17,500 FWHM, a maximum injection time (max.) of 120 ms and a fixed first 
mass of m/z 100. Peptides with a charge of +1, greater than 6, or with unassigned charge 
state were excluded from fragmentation for MS/MS, dynamic exclusion for 30 s prevented 
repeated selection of precursors. 
For data analysis obtained data was processed using MaxQuant software (version 1.5.7.4, 
http://www.maxquant.org/) (Cox et al. 2008) with label-free quantification (LFQ) and iBAQ 
enabled (Tyanova et al. 2016). MS/MS spectra were searched by the Andromeda search 
engine against a combined database containing the sequences from Arabidopsis 
(TAIR10_pep_20101214), the sequence of MYC2-flag and sequences of 248 common 
contaminant proteins and decoy sequences. Further, trypsin specificity was required and a 
maximum of two missed cleavages allowed. Minimal peptide length was set to seven amino 
acids. Carbamidomethylation of cysteine residues was set as fixed, phosphorylation of 
serine, threonine and tyrosine, oxidation of methionine and protein N-terminal acetylation 
were set as variable modifications. Peptide-spectrum-matches and proteins had to pass a 
false discovery rate of 1 %.  
Alternatively, raw data was processed with Proteome Discoverer software (version 
2.2.0.388, ThermoFisher). MS/MS spectra were searched using the Sequest HT function 
implemented in Proteome Discoverer software; using a database containing the sequences 
from Arabidopsis (TAIR10_pep_20101214), the sequence of MYC2-flag and sequences of 
248 common contaminant proteins and decoy sequences. Mass tolerances were set to 10 
ppm for precursor and 0.02 Da for fragment ion masses, respectively. Trypsin was set as 
protease with two allowed missed cleavages and the minimum peptide length was set to 6 
amino acids. Carbamidomethylation of cysteine residues was set as fixed, phosphorylation 
of serine, threonine and tyrosine, oxidation of methionine and protein N-terminal acetylation 
were set as variable modifications. Peptide spectrum match validation was carried out using 
the Percolator function implemented in Proteome Discoverer software. Only high confident 
peptide identifications with false discovery rates ≤ 1 % were considered in the analysis. 
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4.2.4 Molecular biological methods 
4.2.4.1 Isolation of genomic DNA (quick and dirty prep) 
Fresh leaf material (ca. 0.5 cm2) was collected in a test tube and crushed with a pestle. 400 
µl DNA extraction buffer were added to the tube and vortexed. The mixture was cleared by 
centrifugation at 13000 rpm, RT, 3 min. 300 µl supernatant were transferred to a new tube 
and DNA was precipitated by adding 300 µl isopropanol. Tubes were centrifuged at 13000 
rpm, RT, 5 min, washed in 600 µl 70 % EtOH and dried at 40 °C for 5 - 10 min. Dried DNA 
was resuspended in 50 µl ddH2O and samples were kept at 4 °C. 
4.2.4.2 Isolation of genomic DNA (sucrose prep) 
For large numbers of DNA extraction (e.g. for genotyping) I used a method based on 
sucrose that allows DNA extraction in a 96 well plate format (Berendzen et al. 2005). Few 
mg of leaf material were collected in collection tubes (Qiagen) containing one metal bead. 
200 µl sucrose solution were added to each tube and samples were homogenised with 
TissueLyser II (Qiagen). Tubes were then centrifuged at 1000 g, RT for 1 min and then 
placed in a water bath for 15 min at 97 °C. After this, samples were placed on ice for 30 
min, before 1 µl of solution was used for PCR analysis. DNA extracted by this method 
should not be frozen and can be used for up to 7 days. 
4.2.4.3 Isolation of total RNA 
Total RNA was extracted from 4-week-old Arabidopsis plants or Arabidopsis protoplasts by 
using the Plant RNA Kit (Bio-Budget, Krefeld, GER) according to the provided instructions. 
Briefly, samples were homogenised in extraction buffer, loaded on DNA binding columns to 
remove gDNA, precipitated, loaded on RNA binding columns, washed, dried and eluted into 
collection tubes. RNA was processed immediately or stored at -80 °C. 
4.2.4.4 Polymerase Chain Reaction (PCR) 
For standard PCRs I used non-proofreading Phire II DNA polymerase (ThermoFisher), 
while for cloning purposes I used proofreading Phusion HF polymerase (ThermoFisher) or 
Takara PrimeStar (CloneTech). An overview of used polymerases can be found in table 5. 
PCR mix was identical for all polymerases and is shown in table 11. The thermal cycling 
program was adjusted to each polymerase and is shown in table 12. 
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Table 11 - PCR reaction mix  
Component Volume 
10x PCR buffer 2 µl 
dNTP mix (2.5 mM) 1.6 µl 
forward primer (10 µM) 1 µl 
reverse primer (10 µM) 1 µl 
template DNA 0.2 - 10 ng 
polymerase 0.2 - 0.5 µl 
ddH2O to 20 µl 
 
Table 12 - Thermo-cycling programs 
Stage Temperature (°C) Time (Phire II) Time (Phusion, 
Takara) 
Cycles 
Initiation 95 30 sec 5 min 1x 
Denaturation 95  10 sec 10 sec 
30 - 35x Annealing 55 - 60 15 sec 30 sec 
Elongation 72 15 sec/kb 30 sec/kb 
Final extension 72 5 5 1x 
 
 
4.2.4.5 Site-directed Mutagenesis 
To mutate specific nucleotides in a sequence of interest site-directed mutagenesis was 
performed with minor alterations according to the instructions of the QuickChange Site-
Directed Mutagenesis Kit (Agilent, Waldbronn, GER). PCR mix can be seen in table 11. 
Thermo-cycling program differed to the one shown in table 12 in the sense that the PCR was 
stopped after 18 cycles in order to avoid PCR induced sequence mistakes. 
To remove template plasmid from the reaction the methylation sensitive restriction enzyme 
DpnI (NEB) was used. 1 µl DpnI was added to 20 µl PCR mix and incubated for 1 h at 37 
°C. As template DNA is methylated it will be digested, while the mutagenesis carrying non-
methylated DNA will not be affected. 5 µl of digested PCR mix were transformed into 
DH10b and plated on selective LB plates for colony isolation and further cloning. 
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4.2.4.6 cDNA Synthesis 
Total RNA was isolated as described in section 4.2.4.3 and 250 - 1000 ng were used for 
cDNA synthesis. I used cDNA Synthesis SuperMix (Bimake) following manufacturer's 
instructions and diluted cDNA 1:1 when using 250 ng total RNA and 1:5 when using 1000 
ng total RNA. cDNA was stored at -20 °C. 
4.2.4.7 quantitative reverse-transcription PCR (qRT-PCR) 
qRT-PCR was performed with a BioRad CFX96 Touch™ Real-Time PCR Detection 
System. For details see table 13 and table 14. Primer sequences can be found in table 6. For 
data analysis CFX Maestro™ Software (BioRad) was used. 
 
Table 13 - qRT-PCR reaction mix 
Component Volume 
SYBR® Green Supermix 5 µl 
forward primer (10 µM) 0.5 µl 
reverse primer (10 µM) 0.5 µl 
template cDNA 1 µl 
ddH2O to 10 µl 
 
Table 14 - qRT-PCR thermo-cycling program  
Stage Temperature (°C) Time  Cycles 
Initiation 95 30 sec 1x 
Denaturation 95  10 sec 
40x Annealing 55  15 sec 
Elongation 72 10 sec  
Melt Curve 60 - 95   5 sec per 0.5 °C 1x 
 
4.2.4.8 Plasmid DNA isolation from bacteria 
For standard plasmid prep the NucleoSpin® Plasmid Kit (Macherey-Nagel, Düren, GER) 
was used to the manufacturer's instructions. For prepping Agrobacteria the low copy 
protocol was used. 
Protoplast transformation requires large amounts of high quality DNA. For this purpose, the 
NucleoBond® Xtra Maxi Kit (Macherey-Nagel) was used. Typically, 250 ml of bacterial 
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culture were grown and DNA was purified using NucleoBond® Finalizers yielding ~1 mg 
DNA. 
4.2.4.9 Restriction endonuclease digestion of DNA 
DNA digestion was performed to the respective enzyme manufacturer's instructions. 
Typically, 5 - 15 µl DNA were mixed with reaction buffer, 0.3 µl enzyme and brought to a 
final volume of 20 µl. The reaction was incubated at the correct temperature for 1 - 2 h and 
stored at 4 °C. 
4.2.4.10 Agarose gel electrophoresis of DNA 
If not pre-mixed, DNA was mixed with DNA loading dye and loaded on a 0.8 - 2 % (w/v) 
agarose gel in TAE buffer. Typically, gels were run at 120 V for 30 - 45 min. Agarose gels 
were supplemented with 0.2 mg/l ethidium bromide and visualised on a 312 nm UV trans-
illuminator.  
4.2.4.11 DNA purification from agarose gels 
Separated DNA fragments were illuminated on an UV trans-illuminator and cut out with a 
clean razor blade. For further processing the PCR clean-up and gel extraction kit (Macherey-
Nagel) was used to the manufacturer's instructions.  
4.2.4.12 Gateway® DNA cloning 
In this work I mainly used the Gateway® system for DNA cloning (ThermoFisher). To 
create entry clones the sequence of a gene of interest was amplified by PCR adding a 5' 
“CACC” 3' overhang upstream of the start codon. Purified PCR product was then ligated 
into the pENTR™/TOPO-D™ vector (ThermoFisher) following the manufacturer's 
instructions and 2 µl were transformed into E. coli. To create expression clones a LR 
reaction was performed using Gateway LR Clonase II mix (ThermoFisher). Typically, 
reactions were incubated for 1 h at RT and 2 µl were transformed into E. coli (DH10b).  For 
reaction mix see table 15.  
 
Table 15 - LR reaction mix 
Component Volume / Amount 
ENTR clone 25 - 75 ng 
destination clone 75 ng 
ddH2O to 4 µl 
LR Clonase II mix  1 µl 
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4.2.4.13 Golden Gate DNA cloning 
Golden Gate cloning was performed as published (Engler et al. 2008, Weber et al. 2011, 
Engler et al. 2014, Patron et al. 2015). Concretely, for level 0 constructs, DNA was 
amplified using primers with overhangs containing BpiI restriction sites, and a 4 nucleotide 
attachment overhang (5' “TACA” 3'). A typical Golden Gate reaction and the thermo-
cycling conditions are shown in table 16 and table 17, respectively. 2 µl of reaction mix 
were transformed into chemically competent E. coli (DH10b) and plated on selective LB 
plates. 
 
Table 16 - Golden Gate reaction mix 
Component Volume 
10x FastDigest buffer 2 µl 
10 mM ATP 2 µl 
plasmid (insert) 50 ng 
plasmid (backbone 15 ng 
ddH2O to 20 µl 
HF restriction enzyme (BpiI or BsaI) 0.5 µl 
T4 DNA ligase* 0.5 µl 
* For level 0 construction T4 DNA ligase, 1 U/µl was used. More complex assemblies like 
level 1 construction were performed with T4 DNA ligase, HC 30 U/µl. 
 
Table 17 - Thermo-cycling Golden Gate reaction  
Stage Temperature (°C) Time  Cycles* 
digestion 37 5 min 
8 - 50x 
ligation 16  5 min 
inactivation 1 55  5 min 1x 
inactivation 2 85 5 min 1x 
* For level 0 construction 8 cycles were sufficient. More complex assemblies like level 1 
construction were performed with 30 - 50 cycles overnight. 
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4.2.4.14 DNA sequencing 
DNA sequencing was carried out by Eurofins Genomics (Ebersberg, GER) using their 
Mix2Seq kit. Instructions were followed precisely.  
4.2.4.15 In silico sequence analysis 
All sequence data was modified and analysed using CLC Main Workbench software 
(Qiagen).  
For phylogenetic protein alignment, protein sequences were obtained via the Phytozome 
database (http://phytozome.jgi.doe.gov), aligned via MUSCLE 
(https://www.ebi.ac.uk/Tools/msa/muscle), and coloured via BoxShade 
(https://embnet.vital-it.ch/software/BOX_form). 
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